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CHAPTER 1 
 
 
 
 
 
 
 
1. INTRODUCTION 
 
 
 
 
 
 
 
 
 
1.1 Schistosomiasis: a global view 
 
Schistosomiasis, also known as bilharziasis, is a parasitic disease that leads to 
chronic illness. It is the greatest health risk in the rural areas of Central China 
and Egypt and ranks high in several other developing countries. 
Schistosomiasis has been recognized since the time of the Egyptian pharaohs. 
The worms responsible for the disease were eventually discovered in 1851 by 
Theodor Bilharz, a young German pathologist, from whom the disease took 
its original name, Bilharziasis (Halawany, 1952). The disease is indicated 
either by the presence of blood in the urine or, in the case of intestinal 
schistosomiasis, by initially atypical symptoms which can lead to serious 
complications involving liver and spleen (Jordan, 1972). 
The main forms of human schistosomiasis are caused by three species of the 
flatworm, or blood flukes, known as schistosomes (WHO, 1993-1996-2002): 
Schistosoma mansoni, Schistosoma haematobium and Schistosoma 
japonicum. 
S. mansoni causes intestinal schistosomiasis and is prevalent in 52 countries 
and territories of Africa, Caribbean, the Eastern Mediterranean and South 
America (Figure 1.1). 
 
 
 
 
 
 
 
 Figure 1.1 Geographical distribution of S. mansoni
S. japonicum causes intestinal schistosomiasis and is prevalent in 7 African 
countries and the Pacific region  
S. haematobium causes urinary schistosomiasis and affects 54 countries in 
Africa and the Eastern Mediterranean (Figure 1.2). 
 
 
 
 
 
 
 
 
 
People are infected by contact with water used in normal daily activities such 
as personal or domestic hygiene and swimming, or by professional activities 
such as fishing, rice cultivation, irrigation. 
 
 
 
 
 
 
 
 
 
 Figure 1.3. Eggs of schistosomes in the excreta 
Figure 1.2. A geographical distribution of S. mansoni and S. 
h b
Due to lack of information or insufficient attention to hygiene, infected 
individuals may contaminate their water supply with faeces or urine. The 
eggs of the schistosomes (Figure 1.3) in the excreta of an infected person 
open on contact with water and release the larval stage of the parasite, the 
miracidium. To survive, this motile form must infestate a fresh water snail 
(Figure 1.4).  
 
 
 
 
 
 
 
 
Once it has found its host, the miracidium undergoes the intermediate phase 
of its life cycle, that leads to the production and release of thousands of new 
parasites (cercariae). The cercariae erupt from the snail into the surrounding 
water. They can penetrate an individual's skin within a few seconds, 
continuing their biological cycle (in Figure 1.5) once they have made their 
way to the victim's blood vessels. Within 30 to 45 days, the parasite is 
transformed into a worm long 1-2 mm, which is either male or female. The 
female lays from 200 to 2000 eggs per day over an average of 5 years, 
according to the species.  
 
 
 
 
Figure1.4. The Intermediate host: a snail 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5. The life cycle of Schistosoma mansoni provides an example for 
all species of schistosomes. After the eggs of the human-dwelling parasite are 
emitted with the faeces into the water, the ripe miracidium hatches out of the 
egg. The miracidium searches for a suitable fresh water snail, an 
intermediate host. Following penetration, the parasite develops via a so-
called mother-sporocyst and daughter-sporocyst generation to the cercaria. 
The purpose of the growth in the snail is the substantial multiplication of the 
parasite. From a single miracidium a few thousand cercaria, each one 
capable of infecting men, are produced. The cercaria propel themselves in 
water with the aid of their bifurcated tail and actively seek for their final 
host. When they recognise human skin, the penetration occurs within a very 
short time. Following a migration through the body within the bloodstream, 
if they meet a partner of the opposite sex, they develop into sexually mature 
adults.  
Adult schistosomes 
1.2 Infection and Pathogenesis 
 
1.2.1 Epidemiological considerations. 
Schistosomiasis is endemic in 74 tropical developing countries. Some 600 
million people are at risk of becoming infected. It is estimated that 200 
million people are already infected. Extreme poverty, unawareness of the 
risks, inadequacy or total lack of public health facilities together with the 
unsanitary conditions in which millions of people lead their daily lives are all 
factors contributing to the risk of infection. In many areas, a high proportion 
of children between the ages of 10 and 14 are infected, causing grow delay 
(Figure 1.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Urinary schistosomiasis affects 66 million children throughout 54 countries. 
In some villages around Lake Volta in Ghana, over 90% of the children are 
infected by the disease. As with other tropical diseases, population 
Figure 1.6 25 year-old man with advanced 
h
movements and refugees in unstable regions contribute to the transmission of 
schistosomiasis. Rapid urbanization has been accompanied by new foci of 
transmission. The increase in "off-track" tourism has led to increasingly 
serious infections with previously unencountered sequelae, including 
paralysis of the legs. The large fresh water reservoirs associated with dams 
such as Akosombo Dam in Ghana, the Kainji Dam in Nigeria and the Kariba 
Dam in Zimbabwe as well as smaller reservoirs in the Sahel and irrigation 
systems throughout Africa are major transmission foci and thus endemic 
areas for schistosomiasis. Although the majority of people in endemic areas 
have only light infections or no symptoms, the impact of schistosomiasis on 
economic conditions and the general health situation should not be 
underestimated. In the north-east of Brazil, Egypt and Sudan, the work 
capacity of rural workers has been estimated to be seriously undermined. The 
disease also substantially affects children's growth and school performance. 
Moreover the close association of schistosomiasis with natural and artificial 
water reservoirs frustrates the efforts aimed at developing agricolture. 
 
1.2.2 Life cycle and infection behaviour 
The eggs are responsible for most of the pathology associated with the 
disease. The eggs pass through the walls of the mesenteries, and through the 
intestinal walls into the gut lumen. How they achieve this is still not well 
understood, however, it is likely to be a result of a number of interacting 
factors. Physical factors such as the mechanical action of the egg spine, 
helped by the host blood pressure and then by the peristaltic action of the gut 
helps driving the egg into and through the tissues. In addition, the miracidium 
within the egg has been shown to release proteolytic enzymes which may 
help digesting its way through the host tissue. The host inflammatory 
reaction, which is a delayed type hypersensitivity reaction and forms a 
granuloma around the egg, also seems to be essential for successful migration 
of the egg to the lumen of the intestine. Experimental infections in mice 
given anti-inflammatory agents results in reduced granuloma formation with 
the eggs becoming trapped in the intestinal tissue. Not all the eggs pass out 
via the intestine. Many of the eggs are swept back to the liver where they are 
trapped and form liver granuloma. The schistosome eggs travel in the host 
tissues for an average of 6 days, between the time they are laid and the 
moment they leave the host, by which time they are fully embryonated and 
ready to hatch. There are three main factors which are important in the 
hatching of schistosoma eggs: temperature (25-30 °C), light and osmotic 
pressure. On entering a hypotonic environment (fresh water) the increase in 
the osmotic pressure as water enters the egg and the activation of the enzyme 
leucine amino peptidase, inhibited by NaCl, result in rupture of the egg’s 
shell. (Note: when isolating schistosome eggs from mouse livers the eggs are 
maintained in isotonic saline, 0.85%, preventing them from immediate 
hatching) Each egg, which is mechanically ruptured along its long axis, 
releases a highly motile (2 mm/sec) ciliated miracidium. It is noteworthy that 
the sex of the adult worm which will eventually be produced from the 
miracidium is already determined at this stage. Therefore, if a snail is 
infected with a single miracidium all the resulting cercariae will produced 
adults worms in the definitive host which are either all male or all female. 
The miracidium seeks for and penetrates the snail intermediate host. It can 
remain infective for 8 - 12 hr. To increase the chance of the miracidia 
locating the host, they have a negatively geotactic and positively phototactic 
behavioural response which tends to place them in the general environment 
of the snail host, Biomphalaria glabrata. Chemical attractants from the snail 
such as mucus, long chain fatty acids and even amino acids attract the 
miracidia. After the miracidium makes contact with the snail there is a period 
of exploratory behaviour prior to penetration. Seventy percent of the 
miracidia appear to penetrate through the foot of the snail, other penetration 
sites include the tentacles and the edge of the mantle. Penetration is a 
combination of mechanical motion of the apical papillae and histolytic 
secretions released from the penetration glands. The cilia are not lost until 
after penetration is complete. The location of the the sporocyst, the next 
developing stage within the snail, is dependent on the schistosome species: S. 
mansoni and S. haematobium remain at the site of penetration, usually the 
foot, whereas S. japonicum has a preference for cavity organs, viscera and 
heart. The sporocyst enters into mitosis and produces about 35-600 daughter 
sporocysts after about 3 weeks. The daughter sporocysts migrate to the 
digestive glands of the snails and produce the next infective stage, the 
cercaria. The average cercarial output from an infected snail has been 
estimated to be about 1500/day, for a total about 18 days. The period from 
penetration of the snail to release of the cercariae is about 4 weeks. The 
cercariae are released on a circadian (24 hr) cycle during daylight hours. It 
has been determined that the pattern of cercarial shedding is dependent on the 
focus of the infection and the behaviour of the host population. For example, 
one study in Guadeloupe island, where there were both a human and a 
sylvatic foci of infection, showed three different shedding in different 
regions. In the urban area, where the human population was the focus of 
infection, cercariae were shed early in the morning. In a remote country area, 
where the focus of the infection cycled through wild hosts, shedding occurred 
in late afternoon. However, in a rural community where there humans and 
rodents acted as hosts, shedding was found to be intermediate to the other 
two. The cercaria are very active, non-feeding stages which rely on stored 
glycogen food reserves. These reserves appear to vary considerably (4.8 - 
14.2 ng of glycogen /cercariae) and may depend on the nutritional state of the 
snail and level of infection. Glycogen reserves in the cercaria have been 
shown to decline exponentially with time after shedding. The rate of loss is, 
not surprisingly, greater in the tail than the rest of the cercarial body. 
Once released from the snail, periodic bursts of activity keep the cercariae 
just under the surface of the water. Sudden shadows also evoke cercarial 
activity. Once in close contact with the next host, products released from the 
mammal’s skin have a dramatic effect on the cercarial behaviour causing 
continuous swimming motion interspersed with frequent reversals which is a 
typical example of what is known as klinokinetic behaviour. 
Penetration into the host skin has distinct phases: attachment, creeping over 
the skin surface (both triggered by chemical and thermal stimuli) and 
penetration into the epidermis (triggered by chemical stimuli, such as 
aliphatic hydrocarbons and free fatty acids, produced by bacterial esterases 
working on tri-glycerides on the skin). The actual penetration is a combined 
mechanical and secretory process whose initial phase may take as little as a 
few minutes. As penetration proceeds there are structural and physiological 
changes which occur and accompany the transformation from a free-living 
infective stage to a parasitic larval schistosomulum. 
This metamorfosis takes less than one hour: (i) changes in outer membrane 
(The cercarial tegument is surrounded by a trilaminate plasma membrane 
with a thick glycocalyx, wich is lost with the tail at the time of penetration) 
(ii) empting the various penetration glands (iii) release of vesicles from the 
tegumental cell bodies beneath the muscular, into the tegumental cytoplasm 
to form a multi-laminate tegumental surface, which replaces the trilaminate 
membrane (iv) finally, release of contents from oesophageal glands into the 
lumen heralding the start of feeding. This process requires two physiological 
triggers: elevated temperatures and iso-osmotic conditions. The glycocalyx is 
thought to control the surface permeability in fresh water and its loss 
coincides with osmotic sensitivity. 
As well as physical changes there are a variety of biochemical changes which 
also take place during the methamorphosis. Over the first 24 h, there is a 
switch in the larval energy production from an aerobic glycogen based 
metabolism to a predominantly anaerobic one, accompanied by an increase in 
lactate production. At the same time, there is a remarkable turnover of 
surface molecules on the schistosomula surface, marked by the appearance of 
more surface molecules which have low immuno-reactivity. By 24-48 h the 
schistosomula has become completely refractory to antibody mediated 
immune cell cytotoxicity. In addition to providing molecules on the surface 
which mask antigenic epitopes, the schistosomula surface also has the ability 
to coat itself with host molecules. Host erythrocyte surface glycolipids are 
adsorbed onto the schistosomula surface helping to mask sensitive parasite 
epitopes from the host defenses system. The parasites enter the initial 
epidermal layer of the skin very rapidly (less than 30 min) and then come to 
rest when they reach the dermis which appears to present a temporary barrier 
to further penetration. They remain at this location for about 40 h. Then they 
require extra 10 h to locate a venule and a further 8 h to penetrate the venule 
wall. Once in the blood capillaries the schistosomula are carried to the first 
capillary bed, the lungs, where they become lodged and double in size over 
the next few days. This so called “lung phase” lasts from 3-8 days. Following 
this period the larvae make someway their way to the liver, but the exact 
pathway is unknown. Upon reaching the liver the schistosomula, mature to 
young adults pairing 28-35 days post-infection. When the worms are mature 
the paired adults migrate out of the liver to the mesenteries where the female 
begins to lay the eggs.(Figure 1.7). 
 
 
 
 
 
 
 
 
 
 
 
The male and female worms remain in close association, the slender female 
lying in a ventral groove on the male surface called the gynecophoral canal. 
This is an intimate association with the female receiving products, such as 
glucose, trans-membranously from the male. The importance of the 
association is highlighted by the fact that if the female fails to mate it does 
not mature properly and remains stunted. It has been estimated that in human 
infections adult worms can survive in the host for 20-30 years. 
In the mouse model system only about 20% of the initial cercarial inoculum 
makes it to the adult stage. Although there has been much controversy over 
the site of attrition of the larval worms, it now seems clear that the greatest 
loss of larvae occurs during the migration through the lungs, with relatively 
small losses during migration through the skin. 
Figure 1.7. Schistosoma pairs in the mesenteries 
Although many of the eggs pass through the gut mucosa and exit the host 
with fecal material, as many as 50% of the eggs can be swept by the blood 
stream back to the liver, where they become lodged in the liver parenchyma. 
The lodged eggs cause the host inflammatory response leading to granuloma 
formation and liver fibrosis, that is the chief cause of pathology. 
 
1.2.3 Pathology of Schistosome Infections. 
The pathology associated with a schistosome infection arises primarily from 
the schistosome eggs (single sex infections, thus no egg production, cause 
little pathology), wherever they are present, both those in the intestine and 
those swept back by the blood to the liver, and on occasion to other tissues 
such as the brain and lungs. At least 50% of the laid eggs fail to reach the 
exterior. 
The clinical signs of the disease pass through different phases:  
The acute stage, often known as Katayama fever, is normally found in 
young children or young adults with no previous exposure to the disease, and 
is particularly prevalent in individuals with S. japonicum infections. The 
acute reaction is in response to the sudden high level of antigen exposure and 
is usually associated with the onset of egg deposition. Clinical symptoms 
consists of skin rashes, asthma-like episodes, daily fever, dizziness, 
diarrhoea, swollen lymph nodes and aching joints and a number of other non-
specific symptoms. Pathologically one sees large florid granuloma with a rich 
infiltration of eosinophils. Frequently, heavy infections can lead to fibrotic 
chronic schistosomiasis or the death of the patient. 
In chronic schistosomiasis the patient experiences diarrhoea and 
fever. In children the infection can depress their growth rate. The infection 
also leads to enlargement of the liver and spleen. Fibrosis of the liver can 
result in portal hypertension, hepatosplenomegaly, ascites formation, 
oesophageal varices leading to fatal hematemesis (vomiting blood). In S. 
haematobium, fibrosis of the bladder may lead to ureteric obstruction, 
pyelonephritis and hydronephrosis and finally to renal failure. 
Over about a 16 day period, after the deposition, occurring predominantly in 
the periportal area, the egg, becomes surrounded by a dense infiltrate 
composed mainly by lymphocytes, macrophages and a variable number of 
eosinophils, held together in a extracellular matrix (Figure 1.8). 
 
 
 
 
 
 
 
 
 
 
In athymic mice such lesions do not occur, whereas mice with impared B-cell 
function still exhibits normal granuloma formation. Therefore granuloma 
formation is a T-cell dependent and T-cell mediated process. 
Eggs cannot pass through the capillary beds as the blood flows through the 
liver because of their size. The size of granuloma and cell composition vary 
depending on the schistosome species, the host species and the intensity and 
duration of the infection, and even tissue location; however, the main factor, 
is how immunoresponsive the host is to the schistosome egg antigen. 
Although some of the tissue responses are due to the physical presence and 
Figure 1.8 Granuloma formation around 
damage by the eggs, most of the outcome is due to the host response to the 
soluble egg antigens (SEA) released through submicroscopic egg’s shell 
pores. 
In normal hosts, reactivity to SEA, peaks early, producing large florid lesions 
but as the infection becomes more chronic, i.e. by 8-10 weeks post infection, 
granulomas tend to become relatively smaller due to a modulation of the host 
hypersensitivity response.  
Activated T-helper cells are instrumental in the induction of IL2, which is the 
principle cytokine required for the formation of normal granulomas. Down 
regulation of the production of this cytokine is initiated by a subset of 
suppressor-inducer T-cells, but modulation is immunologically complex. 
Finally, immunoregulation of the granulomas requires multiple effector 
systems working together to achieve a deceptively simple host adjustment to 
the persistent generation of parasite antigens. This modulation can be 
regarded as beneficial to the long term maintenance of the adult parasite and 
its life cycle; but it is obviously a delicate balance: in fact both the cases of 
no immuno-depression and complete immunosuppression result in high host 
mortality. 
 
1.3 Control of Infection 
 
The WHO priorities to control infection are: health education, supplying 
drinking water and planning adequate healthcare facilities, diagnosis and 
treatment, management of the environment, control of the intermediate hosts 
(freshwater snails) 
The global distribution of the disease has changed significantly in the past 50 
years, with control successes achieved in Japan and in other restricted areas 
in Asia, the Americas, North Africa and the Middle East. However, despite 
this progress the disease remains endemic in a lot of developing countries (as 
already showed). 
Immunological intervention in the form of a schistosome vaccine would 
complement the success of present efforts in controlling strategies. 
Nevertheless, it is doubtful whether an effective vaccine will be ready for use 
within national control programmes, in the next future, the main reason for 
pessimism being that schistosomiasis does not confer immunity and multiple 
reinfestations are common. 
As we have already mentioned in the previous paragraph, adult schistosomes 
reside in the capillary net of the abdominal organs and avoid host immune 
attack by various mechanisms, the most important of which is the adsorption 
of host antigens to the worm surface. The disease is caused by a 
granulomatous reaction against the large share of the eggs production, most 
of which fails to be excreted from the host. Therefore the main clinical forms 
of disease are due to the eggs, either arrested in the liver, causing 
hepatomegaly and associated pathology, or occupying the bladder wall 
resulting in urinary obstruction, kidney damage and frequently bladder 
cancer. The severity of morbidity is related to the intensity of infection and, 
as the parasite does not reproduce in the human host, clinical signs will not 
appear until the worm burden has been boosted by recurrent infections and a 
sufficient number of egg-associated granulomas have been generated. This 
process is decelereted by the diverse degrees of immunity developed by 
endemic populations, but, because a balance must be struck to reduce the risk 
of overstimulating the granuloma reaction towards the egg, protection builds 
up slowly and is only partial. It is apparent that, the equilibrium between 
opposing immunological mechanisms is a delicate one, and the need for it 
precludes the classical approach to vaccine development. 
Most schistosome antigens were initially identified in S. mansoni as this 
species can be adapted to the laboratory with relative ease. Several antigens 
have reached an advanced phase of development. WHO/TDR (Special 
Programme for Research and Training in Tropical Diseases) has developed a 
programme to assist selection of promising antigens for further development. 
(Table 1.1). 
 
Table 1.1 Mayor Schistosome antigens selected by WHO. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
With the great majority of published work carried out with S. mansoni, it is a 
safe bet that a vaccine against this species will be developed first. 
Anyway, it is unclear how proteins that are predicted to be cytosolic, such as 
Sm14 (Moser et al. 1991), GST (glutathione S-transferase; Balloul et al. 
1987), TPI (triose-phosphate isomerase; Harn et al., 1992), could be attached 
to the schistosome surface, since none has a conventional transmembrane 
domain and there is no evidence of a lipid anchor. One possiblity is that 
parasites could be damaged during the course of an infection and soluble 
proteins are adsorbed to the surface perhaps as part of its strategy to acquire 
host antigens that act as an antigenic disguise (Simpson, 1992). On the other 
hand the adsorption of soluble proteins derived from the parasite to the 
surface seems to be relevant for stimulation of a strong protective immunity 
(as is the case of the vaccine candidates GST and TPI). Interestingly, there is 
a striking accumulation of actin in areas of tegument recovering from damage 
(Matsumoto et al., 1989). Thus, actin or other tegumental proteins are 
possibly capable of interacting with some soluble proteins allowing 
attachment to the tegumental surface. There are currently investigation on 
possible mechanisms of protein adsorbtion to the tegumental surface and the 
interaction of protein species within the tegumental membrane. 
The selection of vaccine candidates favoured antigens showing high rates of 
protection, together with additional advantages, such as the effect of 
glutathione s-transferase (GST) on schistosome fecundity (Capron et al 1992) 
and the cross-reactivity displayed by the fatty acid binding protein antigen 
against fasciolasis (an economically important disease of cattle; Tendler et al. 
1996). Other criteria included the ease of large scale production, the use of 
adjuvants accepted for human use, the quality of research reported and the 
number of publications. 
Chemotherapy can delay morbidity but must be reiterated periodically. 
However, morbidity could possibly be suspended permanently, even with 
continued trasmission, if chemotherapy were followed by vaccination. The 
impact of “Trikle infection” is , however, an open question as the short life 
span of mice and hamsters makes it difficult to emulate this situation 
experimentally. 
Effective drugs, e.g. trivalent antimonials, were introduced in 1918. In the 
1920s copper sulphate was shown to be lethal to the aquatic vectors of S. 
mansoni and S. haematobium and lime was first used to attack the 
amphibious vectors of S. japonicum (Taylor, 1994). 
Currently, diagnosis followed by appropiate chemotherapy remains the 
milestone of control strategy. At the moment, only three effective and safe 
drugs are available for treating schistosomiasis: oxamniquine, metrifonate 
and praziquantel, all against the adult worms. At present praziquantel is the 
drug of choice for the treatment of all forms of schistosomiasis. It has thus 
been administered to millions infected individuals in endemic countries. The 
progressive reduction in costs over the past ten years has also made the drug 
more readily available. This scenario, however, has recently been tainted by 
reports of low cure rates in Senegal and the isolation of praziquantel-resistant 
schistosomes in laboratory. In the meantime, there is a need for increased 
vigilance in both monitoring and reporting of any emerging praziquantel 
tolerance/resistance, which would obviously have major implications for 
control strategies in the future. There is also a strong need to promote 
research and development of additional anti-schistosomal drugs. The detailed 
molecular mechanism of action of praziquantel has not yet been elucidated, 
but a few phenomena connected with its effects are well known (Cioli and 
Pica-Mattoccia, 2003). The most obvious and immediate modification that 
can be observed in schistosomes exposed to the drug either in vivo or in vitro 
is a spastic paralysis of the worm musculature and morphological alterations 
in the worm tegument. These alterations are accompanied by an increased 
exposure of schistosome antigens on the parasite surface (Harnet and Kusel, 
1986). Some of the drug exposed antigens have been identified and appear to 
be connected with the host immune response that is required for a complete 
activity of praziquantel (Brindley et al. 1989). 
The other antischistosomal drug available on the market, oxamniquina, has 
an excellent record of effecacy and safety for the tratment of infections 
caused by S. mansoni (Foster 1987), but is not active against the other human 
schistosomes.  
The third antischistosomal drug, metrifonate, active only against S. 
haematobium; rarely employed and is no longer available as a brand product, 
although it can still be found as a generic drug. Therefore a control strategy 
based on early diagnosis and treatments is actively schemed by research 
laboratories. 
1.4 Actual research directions 
 
Two main areas of research can be identified, one aiming at the production of 
vaccines and the other at improving on the limited a number of 
antischistosomal drugs. As with all infection diseases, a preventive vaccine 
would be the ideal solution, but it may not be easy to implement since natural 
infection leaves very little immunity. For the same reason, chemotherapy can 
be effective but inevitably requires multiple expensive treatments due to the 
high rate of reinfection. Interestingly, one of the effects of chemotherapy with 
praziquantel is to blister the surface skin of the schistosome, thereby 
penetrating the shield that makes it invisible to the host, and rendering it 
vulnerable to specific immune attack and destruction by the host effector 
cells. A combination of chemotherapy with a vaccine cocktail strategy could 
therefore well be the main hope for controlling schistosomiasis. 
Compared to diseases of the developed world, very little investiment is being 
made on schistosomiasis research. Innovative approaches based on 
technological advancements developed in other areas, could be particularly 
beneficial in this relatively neglected field of schistosomiasis. The resources 
necessary for a structural biology project on Schistosome will require 
extensive collaboration between groups performing the genomic, proteomic 
and the structural and functional work.  
In this respect, we started a collaboration with the Institute Pasteur of Lille 
(France) and the Institute of Cell Biology of Monterotondo of  the Consiglio 
Nazionale delle Ricerche (Italy). Target proteins of adult worms were 
selected considering their potentialities for a possible cure. The selection 
criteria for the proteins were: (i) having a role in some of the specific 
processes of the schistosomes; (ii) the possibilities to be drug targets; (iii) a 
demonstrated antigenicity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 2 
 
 
 
 
 
 
 
2. RESEARCH THESIS PLAN 
 
 
 
 
 
 
 
 
2.1 The target metabolic pathway: uptake of 
Arachidonic acid and biosynthesis of prostaglandin D2 
 
The inhibition of Langerhans Cell (LC) migration plays a key role in immune 
defense mechanisms and in numerous immunological disorders. It was found 
that PGD2, but not the major eicosanoids produced by the schistosome, 
specifically impedes the tumor necrosis factor-α (TNF-α) triggered migration 
of LCs through the adenylate cyclase-coupled PGD2 receptor. Thus, it was 
proposed that the inhibition of LC migration could represent an additional 
stratagem for the schistosomes to escape the host immune system; and that 
the PGD2 may play a key role in the control of cutaneous immune response 
(Mountford and Trottein, 2004). 
Among the various life cycle stages, the tissue migratory stages of the 
parasite appeared to produce substantial amounts of PGs.  
Previous studies showed that the infective stage of S. mansoni (cercaria) 
requires and is able to produce a wide range of eicosanoids and 
prostaglandins which are potent regulators of immune response (Fusco et al., 
1986). Cercarial eicosanoid production was related to the fatty acid 
concentration (Salafasky et al., 1984). Various eicosanoid classes were 
associated with cercarial penetration and transformation. Penetration rates 
were correlated with increasing leukotriene and hydroxyeicosatetraenoic acid 
levels, while transformation rates were correlated with increasing 
prostaglandin levels. A Correlation between eicosanoid production and 
penetration and transformation rates, strengthened the hypothesis that 
successful cercarial penetration and metamorphosis are dependent on both 
skin essential fatty acid levels and cercarial eicosanoid production (Fusco et 
al., 1986). Interestingly in vitro, in the absence of polyunsaturated fatty acids, 
no trasformation of cercariae in schistosomula occured and no PGs were 
detected in the culture supernatant (Ramaswamy et al., 2000). This means 
that schistosomes, have a metabolism for PG production similar to that of 
mammals. 
In fact schistosomes lack pathways for long chain fatty acid de novo 
synthesis, and thereby derive essential lipids from host’s blood (Moser et al., 
1991). It has been reported that there is a 32.5% increase in the surface area, 
and therefore of the lipid membrane, during the first 3 days in the 
schistosomal development in the vertebrate host (Samuelson et al., 1980). 
The fatty acid status of mice 6 weeks after infection with S. mansoni was 
investigated and compared with that of uninfected mice. Some fatty acids 
including linoleic acid and arachidonic acid, were significantly reduced in the 
plasma of infected mice (Baumheuer et al., 1994); moreover, it was observed 
that arachidonic acid, the immediate precursor of eicosanoid hormones, is 
incorporated by the parasite more readily than other lipids (Rumajanek et al., 
1980). A cercariometric method to monitor the presence of cercariae based 
on its need of fatty acids has been developed(Ahmed et al., 2002). 
Summarizing: (i) the cercariae are not able to synthetize fatty acids and 
respond to the presence of unsaturated fatty acids (such as ACD) to start skin 
penetration and transformation in schistosomuli, (ii) the schistosomulum 
starts prostaglandin synyhesis in a quantitative way only in presence of 
unsaturated FAs and (iii) a product of this metabolism, PGD2, is crucial to 
circumvent the host immune response and thus, to start infection. 
Therefore, incorporation of arachidonic acid and its transformation into PGs 
has been chosen as a promising subject to investigate in this research thesis, 
since interfering with either fatty acid uptake or metabolism may constitute 
an important therapeutical approach. 
Within this framework we decided to choose one candidate per each path. 
 
2.1.1 Fatty acid transport. 
Schistosomes have a strong requirement for lipids in order to synthetise fatty 
acid derivatives and to maintain their complex membrane system. Thereby, 
these parasites need a specific mechanism of transport to acquire lipids from 
host cells. Uptake and transport of fatty acids and other lipids in S. mansoni 
depend (probably to a large extent) on  the fatty acid binding protein (Sm14) 
(Moser et al., 1991). Sm14 is present in all the stages of the life cycle and is 
localized in the external cell layer, i.e. near the interface between the parasite 
and the host (Brito et al., 2002). 
 
2.1.2 Prostaglandin D synthase activity 
The key parasite enzyme responsible for PGD2 production has recently been 
identified as being a 28 kDa glutathione-S-transferase (termed 28GST) which 
has PGD2 synthase (PGDS) activity (Figure 2.1; Herve et al., 2003). These 
findings suggest a crucial role for 28GST, and its product PGD2, in the 
inhibition of Langerhans cell and in the regulation of the immune response 
during early stages of schistosome infection. 28GST also possesses important 
functions for the parasite because it actively participates in the detoxification 
of parasite and host-derived products (through its GST activity) and appears 
to be crucial for parasite fertility (probably through its PGDS activity). 
Therefore, inhibition of the enzymatic (GST and PGDS) activities of 28GST 
might be critical for the parasite survival. We focused on the protein 
expressed by S. haematobium and therefore will refer to it as Sh28GST. 
 
 
  
 
 
 
Figure 2.1 Synthesis of PGD2 performed by schistosomial GSTs 
 
Moreover, these two proteins fulfil also the third criterion (see section 1.4) of 
choice, being two of the six vaccine candidates against schistosomiasis 
selected by WHO (see Table 1.1). 
 
2.2 Aim of the work 
 
The structural and functional characterization of Sm14 and Sh28GST was the 
aim of my Ph.D work. No structural studies have been done on either these 
two proteins, if one excludes the molecular modeling of Sm14 appeared in 
1996 (Tendler at al., 1996). 
The structural characterization has been achieved through X-ray 
crystallography, while the functional one has taken advantage of 
spectroscopic and rapid kinetic techniques. The goal of the structural 
analyses of these proteins was to obtain a detailed atomic description of the 
molecular interactions and reactivities with the physiological ligands in order 
to (i) design new inhibitors, and (ii) explain their antigenic properties, thus 
leading to more efficacious drugs and vaccines and/or new diagnostic test for 
the infection. 
A thorough functional and structural characterization requires substantial 
quantities of the protein of choice. Therefore heterologous expression in E. 
28GST 
PGH2 PGD2 
coli. has been used to scale up production. The proteins so obtained were 
purified to homogeneity and suitable crystallization conditions were 
discovered. Crystal diffractions data allowed, through different experimental 
techniques, to obtain electron density maps, from which the protein model is 
finally built and refined.  
In this thesis I report the crystal structures of the Sh28GST, a multifunctional 
enzyme involved in host-parasite interactions and presently considered as a 
promising vaccine candidate against schistosomiasis and of Sm14, a protein 
involved in lipid trafficking. 
The structures of the GSH-free enzyme, as well as the partially and fully 
GSH-saturated enzyme, exhibit a unique feature, absent in GST structures: 
the invariant Tyr10 side chain occupies two positions (Johnson et al., 2003). 
The structural constrains responsible for the double conformation are also 
conserved in the structure of the Y10F mutant. The presence of the 2 
conformers of Tyr10 provides a clue about clarifying the multiple catalytic 
function of Sh28GST and allows us to hypothesize some new enzymatic 
mechanisms of reaction. Understanding the mechanism of Sh28GST in the 
activation of (GSH) and in the isomerization of PGs is the first step towards 
the design of new drugs with a higher inhibitory activity. 
Moreover, the proposed mechanism could be general for other GSTs 
belonging to similar classes; GSTs were related to various pathogenesis 
phenomena in human, and the study of the structure-function relationships in 
the interaction with its ligands, has a high pharmaceutical relevance 
(Armstrong, 1997), as demonstrated by the fact that the search of new 
inhibitors for this family of proteins is a fundamental and up-to-date task for 
several pharmaceutical companies. 
Sm14 was crystallised with bound oleic acid (OLA) and arachidonic acid 
(ACD).  
The 3D structures of the complexes of Sm14 with ACD and oleic acid (OLA) 
were solved by means of X-ray crystallography at 2.4 and 1.85Å, 
respectively. Moreover, we characterized the binding and release reactions of 
Sm14 and several important FAs using 1,8-anilino-naphtalene-sulphonic acid 
(ANS) as a competitor. The ligand with highest affinity, when water 
solubility is taken into account (Richieri et al., 2000), is ACD, a compound 
essential to schistosomes. ACD is incorporated by the parasite more readily 
than other lipids (Rumjanek et al., 1980) and is the immediate precursor of 
eicosanoid hormones, including the prostaglandins, critical in facilitating the 
skin penetration process of cercariae (Angeli et al., 2001). Kinetic 
experiments were performed to clarify the mechanism of competition 
between FAs and ANS; a ternary complex between the protein and the two 
ligands was postulated to account for the complex reaction mechanism. Since 
affinities for FAs were shown to be pH dependent, pH jump experiments 
were performed which proved the presence of a slow pH dependent 
conformational change, whose physiological relevance is also discussed. 
A comparison of the functional data and the two structures obtained by X-ray 
crystallography explains the structural basis of ligand selectivity. Finally, the 
3D-structure of Sm14 also allowed us to structurally highlight two previously 
described antigenic determinants of the protein. 
Comparison with homologus FABPs suggests that the binding site of Sm14 is 
optimized to fit ACD, the precursor of prostaglandins (Angelucci et al., 
2004). 
 
 
CHAPTER 3 
 
 
 
 
 
 
3. GLUTATHIONE S-TRANSFERASE FROM 
SCHISTOSOMA HAEMATOBIUM 
 
 
 
 
 
 
 
 
 
3.1 GSTs: What are they good for? 
 
The discovery in 1961 of a catalytic activity for the addition of glutathione 
(γ-glutaminylcysteinylglycine, GSH) to 1,2-dichloro-4-nitrobenzene in 
cytosolic liver extracts (Booth et al., 1961) initiated three decades of 
increasing interest in the genetics and enzymology of the glutathione 
transferases (GSTs), culminating in the elucidation of the three-dimensional 
structures of several cytosolic isoenzymes in the first half of this decade 
(Wilce and Parker, 1994; Armstrong, 1997). The structural information had a 
profound impact on our understanding of the catalytic mechanisms of the 
glutathione transferases, the evolution of their fold, and the molecular basis 
for their enzymatic activity. Mammalian GSTs play several physiological 
roles, which include: detoxification of endogenous and xenobiotic 
compounds, by means of the S-linked addition of GSH to electrophilic 
compounds to facilitate extrusion from cells; simple binding of target 
compounds for transport or sequestering; isomerization of steroid 
intermediates and other compounds; and finally eicosanoid biosynthesis 
(Sheehan et al., 2001).  
The GSTs catalyze the general reaction shown below (Scheme 3.1): 
 
 
Scheme 3.1 
GSH + R-X → GSR + HX  
 
 
and in Scheme 3.2 in more details, with 1-chloro-2,4-dinitrobenzene (CDNB, 
the model compound used to test the activity of GSTs, as R-X): 
 Scheme 3.2 
 
 
 
 
 
 
The issues with respect to how these enzymes function can be framed by two 
general categories of questions, addressing on one hand how the enzyme 
recognizes and activates glutathione for nucleophilic attack and, on the other, 
how, or even if, the enzyme specifically recognizes electrophilic substrates 
(R-X). There are both cytosolic and microsomal GSH transferases that are 
involved in the metabolism of xenobiotics. The cytosolic or soluble enzymes 
derive from a super-family of genes that encodes at least six individual 
classes of enzymes, five of which are known to be present in vertebrates. The 
soluble enzymes defined to date are invariably either homodimeric or 
heterodimeric species. However, heterodimers  can be formed only between 
subunits of the same enzyme class. Three-dimensional structures of at least 
one representative of five of the enzyme classes are known. The structures 
have revealed basic features of each enzymatic class and catalytic features of 
the enzymes. For example, both the subunit interface and the active site 
residues involved in the ionization of GSH have evolved considerably though 
not in tandem. Unfortunately, the nomenclature for the various enzyme 
classes from species other than humans remains unsettled. A nomenclature 
has been agreed with the human cytosolic enzymes which is, in theory, 
applicable to all vertebrate GSTs and extendible to prokaryotes and other 
organisms (Mannervick et al., 1992). The human enzymes are named with 
respect to the class in which they fall (alpha, mu, pi, kappa, sigma and theta). 
 
3.2 Schistosomial glutathione s-transferases: discovery 
and relevance of their antigenic properties 
 
The 28 kDa glutathione S-transferase of S. mansoni (Sm28GST) could be 
considered today as the best characterized [(molecular cloning, full sequence 
of the chromosomal gene (McNair et al. 1993) and crystallisation (Trottein et 
al. 1992b)] and the most tested vaccine candidate antigen of the parasite. The 
protective properties of this molecule have stimulated work both on the GSTs 
of other schistosome species and on other enzymes involved in detoxification 
and antioxidant pathways.  
Schistosome GSTs were first identified as potential targets of protective 
immunity by two separate approaches. The identification of a 28 kDa fraction 
of soluble S. mansoni adult worm antigens that elicits a protective antibody 
response and confers a high degree of protection to both rats and mice 
(Balloul et al. 1985) was followed by cloning of the cDNA encoding the 
major antigenic component of the fraction (Balloul et al. 1987a) which was 
identified as a GST (Taylor et al. 1988). The recombinant protein elicits 
protective immunity in rats, hamsters (Balloul et al. 1987a), baboons (Balloul 
et al. 1987b) and mice (Boulanger et al. 1991). The level of protection 
conferred against infection varies from an average of 50-70% in rats to 40-
50% in mice and 40% in baboons. The relevance of the choice of the 28GST 
as vaccine candidate has been strengthened by vaccination experiments 
performed in Sudan against cattle schistosomiasis due to S. bovis (Bouchara 
et al. 1993).  
General discussions of immune protection against schistosome infection have 
concerned a reduction in the numbers of parasites recovered from immunized 
animals compared to non-immunized controls. The experiments in baboons 
using recombinant Sm28GST highlighted a different protective effect of 
immunization, which until recently had not been demonstrated with any other 
antigen. This effect was a reduction in female worms fecundity reflected in a 
reduced excretion of eggs by immunized animals. Moreover, a reduction in 
tissue egg loads was reported in mice immunized with Sm28GST and 
challenged with S. mansoni (Boulanger et al. 1991) and in cattle immunized 
with native Sb28GST and infected with S. bovis (Bouchara et al. 1993). This 
particular protective effect could be related to the inhibition of the GST 
enzymatic activity by antibodies (Xu et al. 1991), a vital activity for the 
survival of the parasite in the definitive host, and probably to the PGDS 
activity as well (demonstrated for Sm28GST and Sh28GST; Angeli et al., 
2001) that may modulate the host immune response to infection by inhibiting 
the migration of epidermal Langerhans cells to the draining lymph nodes. 
Thus, these findings open new and accessible concepts in vaccine research 
against schistosomiasis, dedicated to the reduction of the parasite fecundity, 
more in terms of anti-pathological vaccines than in terms of eradication of the 
parasitic disease in the definitive host. Indeed, a vaccine, aimed at preventing 
the development of the chronic forms of the disease, has become a major goal 
for applied research, reinforced by the recent emergence of schistosome 
strains naturally resistant to chemotherapy (Fallon et al. 1996). Indeed more 
experimental work is required to elucidate how host’s antibodies reach an 
intracellular target such us Sh28GST. 
 
 
3.3 The 28kDa Glutathione S-transferase from 
S. haematobium 
 
The recent achievements on S. haematobium infection in human populations 
obtained from epidemiological studies, and the results acquired from the 
research on experimental models of urinary schistosomiasis, give the 
opportunity to define the parameters for a vaccination in man using 
Sh28GST. Moreover, the S. haematobium protein showed to be the most 
cross-protective among the 28GSTs; in that way, Phase I clinical trials of 
Sh28GST in conventional vaccine formulation took place in Europe in 
December 1997. Phase II has been already designed in three endemic 
countries for the following years. These trials will represent a major 
milestone in the achievement of the future vaccine against schistosomiasis. 
On the basis of sequence comparison, schistosomal 28 kDa GSTs would 
belong to the so-called sigma class of GSTs. The enzyme was shown to have 
high transferase activity with model compound (CDNB), fatty acid 
hydroperoxide-GSH peroxidase activity (Taylor at al., 1988) and eicosanoid 
synthesis (Hervé et al., 2003). Thus, Sh28GST is a multifunctional enzyme 
which plays key role in the host-parasite interactions. In this work we present 
high-resolution structures of Sh28GST, at different level of saturation with 
GSH, and the structure of the Y10F mutant. These structural data allowed us 
to understand the particular chemical properties of this enzyme, to 
hypothesise new enzymatic mechanism for both its activities and to locate 
new portions of the polypeptide chain as possible targets for drugs-design.  
3.4 Materials and Methods 
 
3.4.1 Expression, Purification, and Preparation of Sh28GST for 
Crystallization.  
The full-length cDNA of Sh28GST was subcloned into pET-24d(+) 
(Novagen), and Escherichia coli BL21(DE3) cells were transformed with this 
expression vector (M. Hervé et al., 2003). Purification of Sh28GST was 
carried out as previously described (Trottein et al., 1992). Initially, the 
recombinant protein was purified by affinity chromatography on a GSH-
conjugated Sepharose column, and eluted at pH 7 using GSH. However, to 
obtain an enzyme preparation without bound GSH, the recombinant 
Sh28GST was affinity-purified twice on GSH-conjugated Sepharose columns 
using 50 mM glycine (pH 10) as eluant (Lien et al., 2001). After elution, the 
protein was dialyzed extensively in phosphate-buffered saline (PBS, pH 7.4) 
containing 1 mM dithiothreitol, passed through polymyxin columns, 
concentrated to 66 mg/mL by ultrafiltration (Amicon PM10), and sterile-
filtered.  
The expression, purification and preparation of the Y10F mutant followed the 
same procedures developed for the wild type, except that the eluition from 
GSH-conjugated Sepharose column was performed ony with GSH. 
 
3.4.2 Crystallization.  
Crystals were obtained under conditions similar to those reported for 
Sm28GST (Trottein et al., 1992). Sh28GST was crystallized by the hanging 
drop vapor diffusion method using a well solution of 2.1 M ammonium 
sulfate, 100 mM Tris (pH 7.2), and 5 mM β-mercaptoethanol. The hanging 
drops consisted of a 1:1 mixture of the well solution with the solution of 
protein at 66 mg/mL in PBS. Large crystals grew within a few days. Crystals 
of the GSH-saturated enzyme were obtained from protein equilibrated with a 
500 M excess of GSH prior to crystallization trials. Crystals of the GSH-free 
and the saturated enzymes were obtained following essentially the same 
procedure, starting with the enzymes prepared in the absence of GSH and 
incubated, prior to crystallization, with a buffered (KPi 20mM) GSH 
solutions, respectively. 
The Y10F mutant crystallised in the same conditions. 
 
3.4.3 Data Collection and Processing.  
Data for the structures were collected at ELETTRA (Trieste, Italy) and at 
DESY (Hamburg, Germany) at ~100 K. Data were processed with the HKL 
suite (Otwinowski and Minor, 1997). Autoindexing produced a list 
containing two likely choices for the space group and unit cell with 
equivalent scores, either C2221 or P21. The data from a home source and 
detector [Rigaku R-axis IV++ detector, coupled to an RU-200 rotating anode 
X-ray (Cu K) generator equipped with focusing mirrors and operating at 50 
kV and 100 mA] to 2.1 Å were used to determine the structure of the partially 
saturated enzyme. The data were originally processed in space group C2221 
with one Sh28GST monomer in the asymmetric unit and the following cell 
dimensions: a = 72.6 Å, b = 77.4 Å, and c = 77.7 Å. During refinement of the 
first structure, it appeared likely that the second possibility (space group P21, 
a = 53.1 Å, b = 77.7 Å, c = 53.2 Å, and  = 93.4 which has a dimer of 
Sh28GST in the asymmetric unit) was afterall the correct choice (see below). 
Thus, the data sets used for refinement were processed using the P21 unit cell. 
3.4.4 Molecular Replacement, Model Building, and Refinement.  
The structure of the partially saturated enzyme was determined by molecular 
replacement in the C2221 unit cell. The ninth search model which was used, 
e.g. the structure of Sj26GST (PDB entry 1GTB), resulted in a clear rotation 
and translation solution using the program AMORE (Navaza, 1994) from the 
CCP4 suite (CCP4). The structure was refined using REFMAC (Murshudov 
et al., 1997), and fit to electron density maps using XtalView (McRee, 1999). 
However, even after the addition of many observed waters, the R-factor 
converged to 26% which C2221 clearly indicated a problem with the 
structure. The most likely problem was due to the choice of space group 
especially given the almost identical length of the b and c axes. Thus, the 
structure was transferred to the P21 unit cell and refined easily, leading to a 
final R factor of less than 23%. This special case of twinning arises from the 
combination of very similar monomers and the almost identical length of the 
b and c axes. Thus, the noncrystallographic 2-fold axis of the dimer found in 
the P21 space group can be "twinned" to a crystallographic 2-fold axis in 
space group C2221. The two monomers in the P21 asymmetric unit are very 
similar but do exhibit fine differences especially in the active site. 
All the structures with different percentage of GSH and the structure of the 
Y10F mutant reported in this work belong to the same space group, with very 
similar unit cell and are solved by difference Fourier method, using as a 
model the partially saturated Sh28GST structure. 
 
3.4.5 Equilibrium Fluorescence Titrations.  
The affinity of Sh28GST and its mutant (Y10F) for reduced GSH was 
determined by taking advantage of the tryptophan fluorescence quenching 
occurring upon binding (Dietze et al. 1996). The experiments were carried 
out using a Spex Fluoromax spectrofluorimeter in 0.1 M potassium 
phosphate (pH 7). Sample solutions of Sh28GST were prepared by diluting 
the stock to concentrations ranging between 0.1 and 5 M and adding reduced 
GSH (Sigma, St. Louis, MO); usually the dilution due to the addition of 
titrant was negligible. The excitation wavelength was 280 nm, and emission 
spectra were collected over the range of 300-400 nm; emission peaked at 337 
nm, and readings at this wavelength were used for the quantitative analysis. 
Measurements were carried out using both preparations of protein: the one 
purified from the GSH affinity column by elution with glycine at pH 10 and 
the other with GSH at pH 7. Addition of GSH up to ~1 µM induced a 30% 
Trp fluorescence quenching. However, in some experiments, further 
quenching (10%) was observed upon addition of very large amounts of GSH 
(up to 0.1 M), suggesting the possible existence of low-affinity GSH binding 
sites, as already reported for similar proteins (Jakobson et al. 1979).  
 
3.4.6 Stopped-Flow Fluorescence Measurements. 
Stopped-flow experiments were carried out using an Applied Photophysics 
(Leatheread, U.K.) MV18 apparatus equipped for fluorescence signal 
detection. The excitation wavelength was 285 nm, and emission was 
collected using a filter with cutoff at 320 nm. Solutions of Sh28GST (10 µM) 
in 0.1 M phosphate (pH 7) were mixed with buffered solutions of GSH at 
concentrations ranging between 15 and 80 µM. The transmittance of the 
samples at 285 nm was higher than 75% (with a 1 cm path length). The time 
courses were fitted to a pseudo-first-order equation to obtain the apparent 
combination rate constants kapp. Linear regression of kapp versus the 
concentration of GSH yielded the intrinsic rate constants for combination 
(kon) and dissociation (koff) of GSH.  
3.4.7 Steady State Determinations.  
The catalytic activity of Sh28GST and of the Y10F mutant was measured 
spectroscopically under steady state conditions, using the chromogenic 
substrate 4-chloro-1,2-dinitrobenzene (CDNB, Sigma). Two typical assays 
were performed, either at a fixed GSH concentration or at a fixed CDNB 
concentration. In the former case, the sample was prepared as follows: a 0.33 
µM solution of Sh28GST (0.5 mL) in 0.1 M potassium phosphate buffer (pH 
7) was pipetted into a 2 mm spectrophotometric cuvette; then GSH was 
added to a final concentration of 2 mM. The reaction was started by addition 
of the appropriate volume of a 0.25 M solution of CDNB in 95% ethanol; the 
final volume ranged between 0.510 and 0.525 mL (Mannervick and 
Guthenberg, 1981). The reaction was followed by the absorbance increase at 
340 nm in a Hewlett-Packard diode array spectrophotometer. The alternative 
experiment was carried out in a similar way, at a constant concentration of 
2.5 mM CDNB. 
 
3.5 Results 
 
3.5.1 Quality of the Structure.  
The structures of Sh28GST free enzyme (A), of Sh28GST partially GSH 
saturated (B, the first one to be obtained), of Sh28GST cocrystallized with 
3.3 mM GSH (C), of Sh28GST cocrystallized in presence of 15 mM GSH 
(D) and of mutant Y10F (E) were refined using high-resolution data, 1.9, 
1.85, 1.65, 1.5 and 1.9 Å, respectively, with each model achieving final R-
factors of 22.8, 22.7, 22.3, 22.5 and 22.9%, respectively (see Table 3.1). 
 Table 3.1. Data collection and refinement summary 
aLast shell (1.9-1.95 Å); bLast shell (1.81-1.86 Å); cLast shell (1.65-1.71 Å); 
dLast shell (1.5-1.56 Å); eLast shell (1.9-1.96 Å) 
 
Except where stated differently, the description of the overall structure is 
referred to the structure at 1.65 Å, the one cocrystallized with 3.3 mM GSH 
(approximately 60-80% GSH saturated). This is possible because the 
structures reported in this work are practically identical (r.m.s. deviations of 
the main chain atoms of the three structures with respect to the one taken as 
reference are less than or equal of 0.35 Å), with similar statistics and showing 
few differences in the active sites, that, anyway, will be reported and 
discussed later in the text. 
The distribution of main chain angles in both models shows 93.7% falling in 
the preferred region of a Ramachandran plot with the remaining 6.3% in the 
allowed region, and none in the less favourable or generously allowed 
regions. Only Glu70, found in the tight turn between β-strand 4 and helix 3 
(see below), exhibits unusual main chain angles, as already reported in all 
 A B C D E 
Resolution 20÷1.9 20÷1.8 20÷1.65 20÷1.5 20÷1.9 
Rmerge 0.07(0.58)a 0.07(0.22)b 0.04(0.47)c 0.04(0.7)d 0.07(0.47)e 
I/σ 39.2(4.2)a 21.5(3.4)b 40.9(2.7)c 15.5(3.9)d 11.4(5.8)e 
Bwilson 29.3 25.2 24.9 22.5 33.8 
R 0.228 0.227 0.223 0.225 0.229 
Rfree 0.298 0.296 0.286 0.263 0.301 
N° H2O 236 226 317 485 220 
N° residue 1(GSH) 1(GSH) 1(GSH) 1(GSH) 1(GSH) 
other GSTs for the Gln, Glu, or Asp residues found at this position. These 
unusual main chain angles are thought to arise from the dual function of this 
residue which is involved in contributing to the dimer interface and also in 
the formation of the GSH binding site (Widersten et al. 1992). The geometry 
of all models is good, given that the geometric restraints which were used 
during refinement of the models led to root-mean-square deviations that were 
canonical for average bond distances and angles of structures at these 
resolutions. Analysis of the many geometrical factors of the two final models 
gives an overall resulting "goodness" or g-factor which is also average for 
structures at similar resolution (Laskowski et al. 1993). At the moment only 
the structures at 1.85 and 1.65 Å (the partially and almost fully saturated with 
GSH) have been deposited in the Protein Data Bank with entries 1OE7 and 
1OE8, respectively (Johnson et al., 2003). 
 
3.5.2 Overall Structure.  
Sh28GST is a dimer, each monomer having the typical N- and C-terminal 
domains (Figure 3.1) making up the canonical GST fold. The model contains 
residues 4-207 in each monomer. The N-terminal domain (residues 4-87), 
which consists of a four-stranded β-sheet (order 2134) flanked by three 
helices, forms a thioredoxin-like fold. The C-terminal domain (residues 88-
207) consists of six α-helices, or seven in case helix 5a and helix 5b are 
considered as separate. The N-terminal domain forms the binding site for 
GSH, called the G-site, whereas the C-terminal domain provides the residues 
of the H-site where the electrophilic substrate is bound. Small but significant 
differences are observed between the two monomers, mostly in the GSH 
binding sites; hence the two monomers are named A and B (Figure 3.1). 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Ribbon-style view of the GSH-saturated Sh28GST dimer, showing 
the bound GSH and the activating conformer of active site residue Tyr10. 
Each monomer is composed of two domains. The N-terminal domain (called 
as domain 1) has a thioredoxin-like fold consisting of a four-stranded β-sheet 
(order 2134) surrounded by three α-helices, and the C-terminal domain 
(called domain 2) is composed entirely of α-helices. The N-terminal domain 
functions mainly to bind GSH, whereas the C-terminal domain forms the 
xenobiotic binding site. The two monomers are indeed very similar; fine 
differences in the active sites are discussed in the text. 
 
The typical overall fold is maintained despite the quite low degree of 
sequence similarity with other GSTs. This is illustrated by a structure-based 
sequence alignment of Sh28GST with (i) the Schistosoma japonicum 26 kDa 
GST (Sj26GST) which was used to determine the structure by molecular 
replacement and (ii) the structure in the Protein Data Bank whose sequence is 
most identical to that of Sh28GST (32%), i.e., that of rat hematopoietic 
PGDS [H-PGDS, PDB entry 1PD2 (Kanaoka et al., 1997)] (see Figure 3.2). 
Sh28GST, like H-PGDS and the sigma class GSTs, lacks a long C-terminal 
extension which occludes the active site in Sj28GST and other alpha class 
GSTs. One distinguishing feature of the Sh28GST fold as compared to other 
GSTs is the increased length of the β-sheet, which is also evident as a gap in 
the sequence alignment between strand 3 and strand 4 (Figure 3.2). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Structure-based sequence alignment using the program 
SEQUOIA of (1) Sh28GST and two structures discussed in the text, i.e., (2) S. 
japonicum 26 kDa GST with bound praziquantel [Sj26GST, PDB entry 1gtb, 
2.2 Å root-mean-square deviation (rmsd) for superposition of 176 
equivalences with 46 identities] and (3) the hematopoietic prostaglandin D 
synthase (HPDS, PDB entry 1PD2, 1.7 Å rmsd for superposition of 192 
equivalences with 61 identities). Equivalent residues (capital letters) are 
those which after superposition are within 3 Å of the corresponding residues 
in Sh28GST. Helices are denoted in red and strands in cyan. A D appears 
above residues in HPDS which contribute to the putative prostaglandin 
binding cleft. Residues Tyr10, Arg16, and Arg21 are discussed in the text. 
 
The crystallographic structure of Sh28GST is compatible with the 
expectation that the protein forms a dimer in solution, as most GSTs do 
(Wilce and Parker, 1994, Armstrong et al., 1997). The dimer interaction 
surface area in the crystal covers 1142 Å2 and 137 shorter contacts than 4 Å, 
is dominated by nonpolar interactions, but has 21 polar interactions, 
including four salt bridges. The relatively high ratio of polar to total contacts 
(21/137) identifies Sh28GST as having a dimer interface similar to those of 
the sigma class GSTs (Sheehan et al., 2001; Ji et al., 1995). The overall 
buried surface area, however, is at the lower end of the range typical for 
GSTs, with monomer-monomer surface areas ranging from ~1000 to ~2000 
Å2 (from the Protein Quaternary Structure Server at EMBL-EBI). Like other 
sigma class GSTs, Sh28GST lacks the hydrophobic "lock-and-key" motif 
found in the dimer interface of the alpha, pi, and mu classes of GSTs 
(Sheehan et al., 2001). The level of sequence identity of Sh28GST with 
nonschistosomal GSTs is at most 32%, which would tend to place the 
schistosomal GSTs in a separate class given that the cutoff of ~30% sequence 
identity has been suggested to distinguish GST classes (Sheehan et al., 2001). 
Schistosomal GSTs are highly homologous, with the lowest level of pairwise 
sequence identity being 77% (Trottein et al., 1992b).  
 
3.5.3 GSH Binding Site.  
Our first structure proved to be partially saturated with GSH despite 
extensive dialysis against phosphate-buffered saline prior to crystallization; 
the active site in each monomer appears to be somewhat less than 50% 
saturated with GSH in the crystal. The occupancy of GSH was estimated by 
comparing the B-factors of the C atoms from GSH with those of the 
polypeptide chain that interact with it (e.g., Glu70). A second structure was 
obtained by crystallizing Sh28GST exposed to 3.3 mM GSH prior to 
crystallization; this structure was very little changed but the fractional GSH 
saturation was higher (Figure 3.3, top panels). Crystallographic data obtained 
at a yet higher GSH concentration (15 mM) suggested an even higher 
occupancy. These data are consistent with the hypothesis that the binding of 
GSH to Sh28GST may display negative cooperativity (as suggested for other 
GSTs, Lien et al., 2001), a point to be further investigated. 
Sh28GST is characterized by a unique feature which, to the best of our 
knowledge, has not been reported for other GSTs, since the crucial and 
invariant active site Tyr10 side chain occupies two distinct positions in each 
monomer (Figure 3.3). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 Stereoview of the electron density (2Fo - Fc at 1; blue contours)of 
the structure of the almost fully saturated Sh28GST at 1.65Å, showing 
evidence for two conformers of Tyr10 in the active site of monomer B, from 
the structure which is almost fully saturated with GSH. The stick model uses 
yellow for carbon, red for oxygen, blue for nitrogen, and green for sulfur. 
The top panels illustrate the level of disorder in three active site residues, 
namely, Phe11, Tyr10, and Arg16. The side chain of Tyr10, shown in the 
activating conformation, forms H-bonds with the S atom of GSH and the 
main chain N atom of Arg16. The guanidinium group of Arg16 forms an H-
bond with the S atom of GSH and a salt link with the carboxylate group of the 
-Gln of GSH. For Phe11, only one conformer is shown. The bottom panels 
show the nonactivating conformer of Tyr10 (center) and its polar interaction 
with the side chain of Arg21 (at the top). The activating conformer of Tyr10 
is only partly visible (facing into the page). The two conformers of Phe11 are 
clearly seen. 
 
Tyr10 has been proposed (Wilce and Parker, 1994; Armstrong, 1997) to 
interact with and help forming the active thiolate of GSH by lowering the 
pKa of the sulfhydryl group from 9 to 6-7. In the free-GSH and in the 
partially (40-60%) and almost fully (60-80%) GSH-saturated crystal 
structures the position of the Tyr10 is poorly dependent by the presence of 
GSH, considering its relative percentage in the two positions as judged from 
the B-factors and the electron density map that outlines the two conformers. 
Anyway, it seems that there is a relationship between the percentage of 
bound GSH and the double position of the Tyr10 side chain, in fact 
crystallographic data obtained at a yet higher GSH concentration (15 mM) 
indicate that the relative amount of the two alternative conformers of Tyr10 
may be altered, even though no experimental conditions were found to induce 
Tyr10 to adopt only the activating position conformer.  
GSH is bound to both monomers in the extended conformation, as observed 
in all other GST-GSH complexes (Koelher et al., 1997), and forms salt 
bridges with three residues from the N-terminal domain (Arg16, Lys45, and 
Glu70) of the same monomer and a fourth one with Asp104 from the C-
terminal domain of the other monomer. Since the side chain of Arg16 is also 
found in two conformations, the number of salt bridges might be counted as 
fewer than four. In addition, GSH forms three H-bonds with protein main 
chain atoms and seven H-bonds with protein side chain atoms, all from the 
N-terminal domain of the same monomer. There are also four H-bonds to 
water molecules, including one to the sulfur thiolate of GSH in the A 
monomer. It is likely that this water plays a role in stabilizing the ionized 
state of bound GSH. In comparison, a survey of GSH-protein contacts in 
high-resolution structures in the Protein Data Bank [alpha class 1F3A (Gu et 
al. 2000), pi class 8GSS (Oakley et al. 1997), mu class 6GST (Xiao et al., 
1999), and Sj26GST 1GNE (Lim et al., 1994)] reveals three salt links for the 
alpha, pi, and mu class GSTs and two for the Sj26GST. In addition, the mu 
class GSTs form two H-bonds with protein main chain atoms, whereas the 
alpha, pi class, and Sj26GST proteins form three H-bonds with protein main 
chain atoms.  
As stated above, two side chains in the G-site have double conformations: 
namely Tyr10 and Arg16 (Figure 3.3, top and bottom panels). One 
conformer, the hydroxyl oxygen of Tyr10 makes a H-bond with the sulfur 
atom of GSH which stabilizes the activated nucleophilic thiolate. In all other 
GST structures with an active site tyrosine, in the alpha, pi, mu, and sigma 
classes (Wilce and Parker, 1994; Armstrong, 1997), this activating conformer 
N-Term 
Arg21 
Glu18 Asp33
Tyr10 
GSH 
is the only one observed. On the other hand, in the GSH-free Sh28GST as 
well as the partially GSH-bound structures, the Tyr10 side chain is found in 
the canonical activating conformer at approximately 40-60% occupancy and 
in the fully saturated enzyme this conformer is occupied at about 80%. Both 
conformers of Tyr10 are stabilized by polar interactions. The activating 
conformer is stabilized by (i) a H-bond between the hydroxyl oxygen of 
Tyr10 and the main chain N atom of Arg16 (as observed in all the other 
structures of GST-GSH complexes) and (ii) a H-bond with the sulfur atom of 
GSH. The nonactivating conformer of Tyr10 is stabilized by an electrostatic 
interaction with the guanidinium group of the side chain of Arg21 in both 
monomers. Arg 21 is kept in place by the interactions between the oxygens of 
Asp33 and Glu18 and the NE and NH2 of Arg21, respectively, as shown in 
figure 3.4. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4. Arg21 is stabilized in Sh28GST by interactions with Asp33 and 
Glu18. In the picture are shown the relative positions of the catalytic 
conformer of Tyr10 and GSH with respect to Arg21. 
The side chain of Arg16 also displays a double conformation, with one 
conformer forming a salt bridge with the carboxylate moiety of the γ-
glutamine of bound GSH and the other forming a H-bond with the sulfur 
atom of GSH, as in alpha class GSTs (Armstrong, 1997). A closer look at 
inspection of the maps (Figure 3.3, top panels) reveals more electron density 
surrounding the activating conformer in the almost fully GSH-saturated 
enzyme. Thus, the conformer of Arg16 which interacts with the GSH sulfur 
atom appears to have a higher occupancy when the active site is 60-80% 
GSH saturated.  
A third residue in the active site, Phe11, appears to have more than one 
conformation (Figure 3.3, bottom panels). The major conformer, observed 
most clearly in the highest-resolution structure of the GSH-saturated 
complex, the side chain in an unstable position which contacts the side chain 
of Phe38 in a symmetry-related molecule belonging to another dimer in the 
crystal unit cell. It is likely that the side chains of Phe11 and Phe38 lie in 
multiple conformers which make stable crystal contacts but which differ 
throughout the crystal. 
Structural data collected on the Y10F mutant partially saturated with GSH 
show a conformation of the active site identical to that of the wild type 
enzyme, and the double conformation of the residue in position 10 (Figure 
3.5). 
The electrostatic interaction between Arg21 and the aromatic ring of Phe10 is 
still present. This proves that the two conformers of the catalytic residue, 
observed in the w.t., is not due to crystallographic artifacts. It is interesting to 
note that the electron density map looks different for Phe10 (as already 
observed for Tyr 10 in the w.t.). The electron density for Phe10, when it is in 
the G-site, is not complete and only the density for the last part of the ring is 
visible, while for the conformer stabilized by Arg21 the density showns no 
interruptions. This could be explained considering that Arg21 interacts with 
all the electrons of the carbon atoms of the aromatic rings and so the the 
aromatic ring is constrained to be firmly perpendicular to Arg21, while in the 
catalytic site the aromatic ring maintains some rotational freedom; moreover 
the H-bonds formed by the phenolic oxygen of the Tyr10 in the w.t. do not 
prevent this rotation on the long axis of the ring and thus the density map 
looks the same in the w.t. structures. 
 
 
 
 
 
 
 
 
 
Figure 3.5. Double conformation of the Phe10 in the structure of the Y10F 
mutant (1.9Å) 
 
3.5.4 Comparison of the G-Site in A and B Monomers.  
In the almost fully GSH saturated (1.65Å), asymmetry between the A and B 
monomers in the homodimer is extremely weak, and is limited to the details 
in the positions of some amino acid residues in the G-site. In any case, the 
weak asymmetry between the two monomers does not significantly correlate 
with the alternative conformations of Tyr10, Arg16, and Phe11. The 
difference in the two monomers is amplified by the position of GSH, since 
Phe10 GSH 
Arg21
the orientation of the S atom is different in the A and B monomers. 
Comparison reveals some differences in geometry around the crucial sulfur 
atom of bound GSH. In the A monomer, the Tyr10 hydroxyl of the activating 
conformer is 4.5 Å from the S atom of GSH; close to this atom are also a 
water molecule (at a distance of 2.95 Å) and the NH1 atom of Arg16 (at 2.86 
Å distance). In the B monomer, the Tyr10 hydroxyl in the activating 
conformation is at a distance of 3.4 Å and the NH1 atom of Arg16 is 2.64 Å 
from the S atom of GSH, with no water within H-bonding distance. The 
calculated distances for the H-bonds between a negatively charged S atom 
and a hydroxyl group, or between a negatively charged or neutral S atom and 
a variously charged water molecule, have been reported (Liu et al., 1993 and 
Orozco et al., 1997, respectively). These calculated distances suggest that in 
the A monomer, the sulfur atom of GSH is negatively charged, therefore a 
thiolate, and makes one H-bond with a positively charged water molecule. 
On the other hand, the Tyr10 hydroxyl oxygen at 4.5 Å is too far from the S 
atom to form a H-bond. In contrast, in the B monomer, the Tyr10 hydroxyl 
oxygen (3.5 Å) is likely to be neutral and protonated and to form a stable H-
bond with the negatively charged S atom. In both the A and B monomers, the 
NH1 atom of Arg16 is probably also positively charged and within H-
bonding distance, though calculations were not reported for this type of atom. 
The asymmetry between the A and B monomers in the homodimer is 
possibly relevant with respect to an observed feature of GSTs (Lien et al., 
2001), namely negative cooperativity, that would be hard to explain in a 
perfectly symmetric dimer. 
The structures of all other GSTs show that invariant Tyr10 is present only in 
the activating conformation, which is most relevant for catalysis. The 
structures of Sh28GST GSH-free, partially and almost fully GSH-saturated, 
reveal that, at least in the crystal, Tyr10 occupies a non-activating 
conformation (see Figure 3.6). Our data do not allow us to precisely estimate 
if the fraction of Tyr10 in the two alternative conformations is the same in 
both the A or B monomer; however, the relevant electron densities and B-
factors are comparable in the two monomers, and thus, we conclude that the 
two conformers of Tyr10 are approximately equally populated in both 
monomers of the active Sh28GST dimer. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 Ball-and-cylinder representation of the two Tyr10 conformers in 
the B monomer of the almost fully saturated enzyme, with a ribbon-style 
(white) representation of -strand 1 and -helix 1. Carbon atoms are in green, 
oxygens in red, and nitrogens in blue, and sulfur is shown in yellow. dThe 
activating conformer of Tyr10 forms an H-bond with the S atom of GSH; the 
nonactivating conformer forms a polar interaction with the guanidinium 
group of Arg21. Interconversion between the two conformers of Tyr10 is 
blocked in the crystal structure by the side chain of Val8 and the loop 
between -strand 1 and -helix 1. 
 Interestingly, in the fully GSH-saturated structure (1.5Å) the monomers are 
identical and the oxygen of the tyrosines in the activating conformation of 
both monomers are found at the same distance to the sulphur atom of GSH 
(3.4Å). Thus, an excess of GSH force the tyrosine to be predominantly in the 
G-site by H-bond interaction, and overcomes the tendency of the two 
monomers to adopt asymmetric conformations. 
 
3.5.5 Comparison of PGDS and Sh28GST H-Site.  
GSTs in general catalyze the nonspecific conversion of the prostanoid 
precursor prostaglandina H2 (PGH2) to three products: PGD2, PGE2, and 
PGF2 (Christ-Hazelhof et al., 1976). A class of GSTs which catalyzes the 
specific conversion of PGH2 to PGD2 has been described (Urade et al., 1987), 
and for rat H-PGDS (sequence in Figure 3.2), the crystal structure has been 
published (1PD2, Kanaoka et al. 1996; Pinzar et al., 2000). Sh28GST, whose 
sequence is 32% identical to that of rat H-PGDS, has been identified as a 
specific PGDS (Hervé et al., 2003). In the H-PGDS structure, there are two 
clefts near the G-site which have been proposed to bind the J- and K-arms of 
the prostanoid precursor, PGH2. In Sh28GST, the side chains of Glu106, 
Tyr110, and especially His169 would interfere with binding of PGH2 in the 
same mode proposed for H-PGDS. Specifically, the side chain of His169 is 
sterically hindered from moving and forms two H-bonds, the first between 
the NE2 atom and the main chain O atom of Arg14 and the second between 
the ND1 atom and the side chain OE1 atom of Glu106. However, the H-site 
near the bound GSH in Sh28GST is quite very open with space for both the 
approach of the PGH2 headgroup near the GSH thiolate and the positioning 
of both arms of the substrate in contact with the protein surface. 
3.5.6 Helix 5A Major Antigenic Peptide.  
Natural antibodies to schistosomal GSTs are known to inhibit the transferase 
activity (Xu et al., 1991); however, this effect is not due to antibodies against 
the most potent antigenic and cross-reactive region of the protein molecule, 
identified from investigations of various antigenic peptides of schistosome 
28GSTs as the Pro115-Lys131 fragment. This region may be important in the 
cross-protection against different schistosome species, including S. mansoni, 
S. haematobium, and Schistosoma bovis (Trottein et al., 1992b). In the crystal 
structure, this peptide contains the last part of the loop between helix 4 and 
helix 5a up until the first residue of helix 5b. The Pro115-Lys131 peptides in 
the A and B monomers are located topologically close to each other and near 
the G- and H-sites, as shown in Figure 3.7. 
 
 
 
 
 
 
 
 
 
Figure 3.7 Ribbon-style view of the Sh28GST dimer showing the location of 
residues 115-131 (top, in VDW balls) which make up the cross-protective 
antigen and its typology and distance from the active site. Also shown are the 
bound GSH (center) and the active site Tyr10 (center left and center right) in 
the activating conformer. These antigenic peptides, located near each other 
on the protein surface, contain many charged residues but do not contribute 
to the stability of the monomer-monomer interface (since they form no 
stabilizing contacts in the Sh28GST dimer). Carbon atoms are shown in 
green, oxygens in red, and nitrogens in blue, and the sulfur of GSH is shown 
in yellow.   
 
3.5.7 Kinetic Characterization of Sh28GST. 
The finding that Sh28GST was partially saturated with GSH in the first 
crystal structure, despite extensive dialysis prior to crystallization, indicated 
that GSH is bound tightly. To measure the affinity of Sh28GST for GSH, we 
exploited the decrease in fluorescence of the protein upon GSH binding, 
mostly attributed to a change in the environment of Trp 41 which forms H-
bond between its side chain NE1 atom and the carbonyl oxygen of the 
glycine moiety of bound GSH (Dietze et al. 1996). Titrations of Sh28GST at 
very low concentrations (0.1 µM) with GSH under equilibrium conditions 
were carried out for the two preparations of the protein. As shown in Figure 
3.8 A, we obtained similar results with a fitted Kd of 3 µM. In addition, we 
employed stopped-flow fluorescence measurements to follow the time course 
of GSH binding which resulted in all cases to a simple exponential. The 
estimated affinity for GSH from these experiments is model-dependent and 
assumes second-order, reversible binding to independent monomers; this 
expectation is consistent with the experimental observations (Figure 3.8 B). 
The stopped-flow experiments, also carried out on both batches of the 
protein, yielded an estimated Kd of 9 µM. Both estimates of Kd (3 µM by 
equilibrium and 9 µM by kinetics) are similar to the smallest previously 
reported values (e.g., 7 µM for an alpha class rat liver GST) (Jakobson et al., 
1979), and are significantly lower than the usual range reported of 300 µM. 
Thus, Sh28GST has an affinity for GSH which ranks among the highest, up 
to 100 times higher than values usually reported for GSTs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 Measurements of affinity of Sh28GST for GSH by equilibrium 
fluorescence titration (A) and stopped-flow kinetics (B). Experiments were 
carried out with two enzyme preparations purified using either GSH 
(squares) or glycine (triangles) to elute the protein from the GSH-Sepharose 
affinity column. The two enzyme preparations gave similar Kd values for 
GSH binding, by both methods. 
For the Y10F mutant, eluted from the GSH-conjugated column with GSH, 
the affinity for GSH is about 30µM, suggesting that the H-bond between the 
Tyr10 and GSH is relevant for ligand binding. 
The transferase activity with CDNB, measured as detailed in Materials and 
Methods, corresponds to a specific activity of 12 mol of product formed per 
minute per milligram of protein, similar to those found for other GSTs, 
including H-PGDS (Thomson et al., 1998; Jowsey et al., 2001). On the 
contrary, the Y10F mutant appears to be practically inactive, for 
detoxification and PGDS activities (Trottein et al., unpublished experiments).  
 
3.6 Discussion 
 
In comparison to other reported GST structures, the residues in the active site 
of Sh28GST exhibit two side chain conformers (Tyr10, Phe11, and Arg16). 
The invariant active site Tyr10 has been extensively studied because of its 
essential role in the transferase mechanism (Armstrong, 1997). As far as we 
know, the non-activating conformer of Tyr10 clearly seen in the Sh28GST 
structure has never been reported before for any of the several GSTs 
containing Tyr at this position. In Sh28GST, the two conformers of Tyr10 
illustrated above have similar occupancies in all the independent derivatives. 
To investigate the conditions which might alter the distribution of the two 
conformers of Tyr10, four more structures were collected at the synchrotron. 
The structure of the GSH-free Sh28GST at pH 7.0 was determined starting 
from the enzyme preparation purified using glycine instead of GSH (see 
Materials and Methods); starting from the enzyme that was partially GSH 
saturated, we collected a data set for a crystal soaked at pH 8.0 to rule out the 
possibility that the bound GSH sulfhydryl had a pKa of >6.2-6.5 (data not 
shown), as reported for other GSTs (Armstrong, 1997); in addition, was 
solved a structure where Sh28GST was cocrystallized in the presence of 
15mM GSH. 
The structures in which we increase the presence of GSH were obtained for 
proteins which have been pre-equilibrated with a different concentration of 
GSH prior to crystallization. Because the enzymes were crystallized starting 
from a protein equilibrated with GSH in solution prior to crystallization, it is 
likely that the distribution of conformers found in the crystal would be 
present also in solution. 
In summary, the three structures at pH 7.0 (GSH-free, partially saturated, and 
almost fully saturated) exhibit similar relative occupancies of the two Tyr10 
conformers (Figure 3.6).  
Can the tyrosine swing in the crystal structure? The two conformers of Tyr10 
are both stabilized by specific polar interactions (see Results) as well as 
favorable steric contacts. As shown in Figure 3.6, rotation of the Tyr10 side 
chain about the C-C bond is blocked in one direction by the main chain of the 
loop between β-strand 1 and helix 1, and in the other by the rather rigid side 
chain of Val8, which is on the same β-strand as Tyr10. Thus, it is very 
unlikely that the two conformers can interconvert in the crystal. 
The fourth structure, solved in presence of 15mM of GSH, presents a higher 
fraction of the Tyr10 in the G-site. This could demonstrate (i) that the 
tyrosine can swing in solution and (ii) that the H-bond between GSH and the 
oxygen of the tyrosine could stabilize this conformer, when the protein is 
fully saturated with GSH.  
Indeed, in solution, large conformational changes between apo and GST-
bound forms of several GSTs have been described (Ricci et al., 1996; Stella 
et al., 1998; Hitchens et al., 2001). In the human P1-1 pi class GST, a 
disulfide bond can be formed between two cysteines which are 18 Å apart in 
the crystal structure (Ricci et al., 1991; LoBello et al., 1998). In the same 
GST, the short 310-helix 2 is disordered in the apo form but ordered in the 
GSH-bound enzyme (Hitchens et al., 2001). In Sh28GST, the short helix 2 is 
both preceded (Phe-Gln-Asp) and followed by a three-residue (Lys-Pro-Thr) 
310-helix which suggests a similar flexibility. In addition to conformational 
fluctuations in tertiary structure, a specific structural rearrangement of the G-
site upon binding of GSH has been suggested for several GSTs (Ricci et al., 
1991).  
To give an explanation for the different fractions of Tyr10 conformers 
relatively to the concentration of GSH, we should admit that the two 
populations of the enzymes (the first with the Tyr10 out of the catalytic site 
and the second with this amino acidic residue in the G-site) have a different 
affinity for GSH. Our hypothesis is that there is monomer heterogeneity, and 
thus a possible negative coopertivity has to be taken into account. We are still 
carrying out studies to elucidate this point. 
 
3.7 Structural data suggest new mechanisms for the 
transferase activity and for PGD2 synthesis 
 
3.7.1 Description of the interaction between Arg21 and the Tyr10. 
Several studies have been carried out on this kind of particular interaction 
that is rarely found in the catalytic site of enzymes (Liu et al., 1993). 
Electrostatic interactions between cations and π-systems may provide 
appreciable interactions energies in proteins (Dougherty, 1996). Theoretical 
and experimental studies, both in gas media and in aqueous media, have 
shown that π-cation interactions could be quite strong (up to 11 kcal/mol), 
NH
NH2
NH
HN
H2N
NH
although the geometry involved could be quite different and consequently the 
energies implicated may vary widely (Figure 3.9). 
 
 
 
 
 
 
 
 STACKED     T-SHAPED 
 
Figure 3.9. The stacked and T-shaped conformation between an aromatic 
ring and an Arg. 
 
The stacked conformation is stabilized through the π-cation as well as 
additional nonelectrostatic effects such as Van der Waals and π−π cation 
interactions. The T-shaped geometry points one of the NH groups at the 
centroid of the ring. T-shaped conformation has been proposed to be stronger 
than the parallel geometry even if it is more rarely found in proteins and the 
on-face hydrogen bond is possible only in this T shaped geometry. 
Weak interactions between aromatic rings and neutral hydrogen bond donors 
have also been suggested to contribute to protein structure and stability. 
However the extent to which these “unconventional hydrogen bonds” 
contribute to protein function remains unclear. An interaction of this kind is 
associated to a binding energy of 3-5 Kcal/mol and distances between 3.0-4.5 
Å. 
ONH
NH2
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It is also clear that if this type of interaction happened between the positive 
nitrogen and the coniugate base of the tyrosine, the energy of binding would 
be improved because the electrostatic component of the interactions is raised. 
Moreover, this could also lower the pKa of the tyrosine (Figure 3.10). 
 
 
 
 
 
 
 
 
Figure 3.10. Electrostatic stabilization of the conjugated base of Tyrosine in 
interaction with Arg. 
 
In GST structure, the contact between Arg21 and Tyr10, and that between 
Arg21 and Phe10 in the Y10F mutant is found at distances that ranging from 
3.0 to 3.5 Å and could be described by two contributions: (i) π-cation 
interaction between the positively charged NH1 of Arg and electron of the 
benzene ring; (ii) on-face hydrogen bond. Clearly, each contribution 
strengthens the other. 
 
3.7.2 Transferase (detoxifying) activity 
In the literature there are two different mechanisms which account for the 
activation of GSH, the step preceeding the nucleophilic attack on the 
substrate (see Scheme 3.2) in other classes of GSTs. The activation reaction 
is a simple acidic-base exchange but the scenario presented in the literature is 
more complex. For example, the two mechanisms proposed for GST A1-1 (a 
class similar to that of Sh28GST) are: (a) the base-catalyzed mechanism 
(Scheme 3.3; Dietze et al., 1996) and (b) the lowering of the pKa of GSH 
(Scheme 3.4; Bjornestedt et al., 1995). 
 
Scheme 3.3 
 
 
 
 
Scheme 3.4 
 
 
 
 
 
In the first mechanism (Scheme 3.3) the ionized tyrosine acts as a base 
extracting the proton from GSH. Several results are in agreement with the 
base-catalyzed mechanism. First of all, the tyrosine has an unusually low pKa 
(8.1-8.3) compared to that of a tyrosine in solution (~10); moreover both the 
unprotonated and protoned states of the tyrosine were shown to be present 
and finally the protonation of the tyrosine seems to be dependent on the 
presence of GSH.  
In the second mechanism (Scheme 3.4) the tyrosine is protonated and works 
as a hydrogen bond donor towards the sulphur atom of GSH, lowering its 
pKa. The experimental data supporting this mechanism are: the pKa of the 
bound GSH is about 6.8 (while in solution the pKa is about 9.8); and the 
G SITE 
catalytic activity (Kcat/Km) decreases whenever the pH is raised and thus the 
active form cannot be the unprotonated species. 
Anyway, both mechanisms cannot clarify the fate of the GSH proton nor the 
amino acid that accepts the released proton.  
We now provide a functional significance to the presence of Tyr10 in double 
conformation in Sh28GST and try to fit our proposed mechanism with the 
experimental data reported in literature for GST A1-1. We remind that in the 
conformer with the tyrosine out of the binding site, the phenolic oxygen is in 
contact with the solvent. Considering the nature of the interaction between 
Arg21 and Tyr10, a unique mechanism for the release of the GSH proton 
comes to mind whereby the swing of the Tyr10 is coupled to H+ dissociation.  
 
 
 
 
 
 
 
 
 
Figure 3.11 Mechanism for the release in solution of the GSH proton for 
Sh28GST 
 
As shown in Figure 3.11 the tyrosinate in the G-site can extract the proton 
from the bound GSH; transition of Tyr10 out of the catalytic site and 
interaction with Arg21, lowers its pKa leading to H+ dissociation. 
This mechanism can account also for experimental data on GST A1-1, i.e.: (i) 
the low pKa for Tyr which may be proper for the non-catalytic conformer; (ii) 
both tyrosine states are present (protonated and unprotonated); (iii) the 
fraction of protonated tyrosine is directly related to the presence of GSH in 
the active site; (iv) the decrease in catalytic activity with increasing pH, 
which stabilizes the tyrosine conformer out of the binding site and hinders its 
return to the G-site. 
Interestingly, such a mechanism whereby a tyrosine can work as a proton 
shuttle, changing its acidic properties through interaction with Arg, has not 
been reported 
On the assumption of a rapid equilibrium between the two conformers, the 
following hypothetical mechanism (Scheme 3.5) can be drawn: 
 
Scheme 3.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.7.3 Comparison with other GSTs. 
Interestingly, Arg21 is totally conserved in all classes of GST which share a 
tyrosine as a catalytic active site residue (Figure 3.12); whereas it is not 
conserved in those classes that have a serine or a cysteine as the catalytic 
residue. Thereby the question arises whether this proposed mechanism could 
be general for this class of GSTs. 
 
 
 
Figure 3.12. Sequence alignment between the N-term of Sh28GST 
(GT28_SCHHA), rat Hematopoietic PGDS (PGD2_RAT), human GST A1-1 
(GTA1_HUMAN) and human GST P1-1 (GTP_HUMAN). The coloured 
boxes mark the residues affecting the stability of the non-activating 
conformer of the enzymes. The red box shows the total conservation of the 
residue (Arg21), the blue the conservation of the chemical properties 
(Asp/Glu in position 33), the green the partial conservation of the residue 
(Glu in position 18, which is not conserved only in human GSTP1-1). 
 
Since Arg21 helps stabilizing the non-activating conformer of Tyr10, we 
suggest that this conformer may not be unique to Sh28GST. In fact, 
inspection of other GST structures (McTigue et al. 1995; Ji et al., 1995; 
Oakley et al., 1997) reveals that the side chain of the Arg topologically 
homologous to Arg21 displays a conformation similar to that seen in 
Sh28GST (Figure 3.13).  
 
  
 
 
 
 
 
 
 
 
 
 
Figure 3.13 Structural comparison of the N-terminal portion of Sh28GST 
(Panel A), H-PGDS (Panel B), human GSTP1-1 (Panel C) and human 
GSTA1-1 (Panel D). 
 
In all GSTs containing Tyr as the catalytic residue, the conserved Arg21 is 
kept in place by interactions with an Asp and a Glu, as observed in Sh28GST, 
with the exception of the pi class GST where only one of the two residues 
that bind Arg through a double H-bond is conserved (see Figure 3.12 and 
3.13). In other GSTs, water molecules fill the space near the guanidinium 
group expected for the nonactivating Tyr10 conformer (if present), requiring 
a slight rearrangement of structure to make room for the phenoxyl group. 
Since the experimental data for the alpha class GSTs are in agreement with 
our proposed mechanism and given the structural observations reported 
above, we propose that the mechanism which seems valid for Sh28GST, may 
be more generally applicable. This is not a minor point if we consider that the 
research of GST inhibitors is a fundamental and up-to-date research task. 
Moreover, the GSTs are detoxifying enzymes, characterized by wide 
substrate specificity, which makes it intrinsically difficult to design inhibitors 
(in this case substrate analogues) active towards enzymes from different 
classes. From a theoretical stand point, if the swing off of the tyrosine is 
involved in the detoxifying activity, as we propose, it may be profitable to 
orient the drug design towards the pocket in which the tyrosine is held by the 
interaction with the conserved Arg (Figure 3.14). On the other hand, if the 
mechanism is unique to Sh28GST, it may be a specific lead to inhibit the 
schistosomial enzyme with clearly interesting therapeutical implications.  
 
 
 
 
 
 
 
 
 
Figure 3.14 Possible target pocket for drug-design 
 
3.7.4 Prostaglandin D2 synthase activity 
Since mammalian sigma class GSTs, as well as several GSTs from 
invertebrates, possess a specific and well-characterized prostaglandin 
synthase activity (Jowsey et al., 2001), it is tempting to speculate that the 
non-activating conformer of Tyr10 may play a role in the prostaglandin D2 
synthase activity (PGDS) of Sh28GST (Hervé et al., 2003). The proposed 
mechanism for PGDS involves two steps (Kanaoka et al., 1997, Figure 3.15). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15 Proposed mechanism for HPGDS (Kanaoka et al., 1997) 
 
In the first step, GSH attacks one oxygen atom in the peroxide ring of the 
prostaglandin, thereby breaking the O-O bond and forming a GSH-addition 
intermediate. In the second step, an unidentified general base (the authors 
hypothesise that could be a deprotonated GSH, coming from the solution) 
extracts a proton from the carbon bonded to the first oxygen atom, 
consequently releasing the product PGD2 and leaving the GSH bound to 
HPGDS.  
In the case of Sh28GST, the PGDS activity may also be facilitated by the 
relatively high and unusual affinity of this enzyme for GSH, which would 
tend to ensure that the intermediate addition product remains bound to the 
protein.  
In this context, apart from specific aspects of the interaction between bound 
GSH and tyrosine (any of the tree mechanisms reported above) and assuming 
that Tyr would loose the proton by swinging out of the binding site, we may 
propose a different and plausible mechanism as presented in Figure 3.16. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.16 Proposed mechanism for the isomerization of PGH2 to PGD2 for 
Sh28GST 
 
The hypothesis is based on the assumption that for Sh28GST as well as for 
HPGDS, the two conformers of the catalytic tyrosine are active and 
interchanging (see Figure 3.13); thus we propose that the tyrosine comes 
back into the G-site to extract the proton from the PG-GSH adduct (Figure 
3.16). This makes it unnecessary to summon a second molecule of GSH in 
the active site to outdraw the proton from the PG-GSH adduct,  
If this is the case, the design of new inhibitors of the detoxifying activity of 
Sh28GST, modelled on the Arg21-pocket (Figure 3.14), could be extended to 
the PGDS activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 4 
 
 
 
 
 
 
4. THE FATTY ACID BINDING PROTEIN 
FROM SCHISTOSOMA MANSONI 
 
 
 
 
 
 
 
 
 
4.1 Fatty acid binding proteins 
 
Mammalian fatty acid binding proteins (FABPs) were discovered in the early 
1970s as abundant cytoplasmatic proteins which bind long-chain fatty acids. 
The FABPs constitute a multigenic family of low molecular mass proteins 
(14-15 kDa). Analysis of their 3-D structures revealed basic structural 
similarities among the members of this family despite low sequence identities 
(Storch and Thumser, 2000). The precise physiological role of FABPs is still 
unclear and different hypotheses have been proposed, including protection of 
cell membranes and enzymes from the effect of high concentrations of free 
fatty acids (FAs) and their acyl-CoA derivatives; storage of FAs; lipids 
trafficking; regulation of cell growth and differentiation (Veerkamp et al., 
1991; Weisiger, 2002). Ambiguities come mainly from the observation that 
these proteins bind with high affinity several hydrophobic substrates and 
reversibly associate with phospholipid bilayers (Kaikaus et al., 1990). Among 
these hypotheses, the involvement of FABPs in the intracellular trafficking of 
lipids to and from cell membranes is the most accredited; an important piece 
of evidence is that the heart fatty acid uptake is decreased in heart-fatty acid 
binding protein gene-ablated mice (Murphy et al., 2004). 
 
4.2 Schistosoma mansoni fatty acid binding protein: 
Antigenic properties. 
 
Sm14 is the second more studied vaccine candidate after GSTs. This is also 
evident when considering the number of published papers about the 
Schistosoma mansoni fatty acid binding protein (Sm14). 
In 1996 (Tendler et al. 1996) molecular cloning of components of protective 
antigenic preparations has suggested that related parasite fatty acid-binding 
proteins could form the basis of the protective immune cross-reactivity 
between the parasitic trematode worms F. hepatica and S. mansoni. 
Molecular models of the two parasite proteins showed that both molecules 
adopt the same basic three-dimensional structure, consisting of a barrel-
shaped molecule formed by 10 anti-parallel β-pleated strands joined by short 
loops, and revealed the likely presence of cross-reactive, discontinuous 
epitopes principally derived from amino acids in the C-terminal portions of 
the molecules. A recombinant form of the S. mansoni antigen, rSm14, 
protected outbred Swiss mice by up to 67% against challenge with S. 
mansoni cercariae in the absence of adjuvant and without provoking any 
observable autoimmune response. The same antigen also provided complete 
protection against challenge with F. hepatica metacercariae in the same 
animal model. The results suggest that it may be possible to produce a single 
vaccine that would be effective against at least two parasites, F. hepatica and 
S. mansoni, of veterinary and human importance, respectively. 
With a view to producing peptides capable of inducing a protective immune 
response against S. mansoni and F. hepatica, the sequence and structure of 
the protective antigens Sm14 and Fh15 were analyzed (Vilar 2003). Their C-
termini showed a high level of sequence conservation which, together with 
models for their three-dimensional structures, aided in peptide selection. 
Vaccination trials in Swiss mice challenged with S. mansoni cercaria or F. 
hepatica metacercaria showed that peptides which included the sequences 
VTVGDVTA or EKNSESKLTQ were capable of inducing levels of 
protection equivalent to the recombinant form of Sm14. These peptides may 
represent an alternative to r-Sm14 for the development of a bivalent anti-
helminth vaccine. 
Recently, the T helper cell 1-mediated immune response elicited by Sm14 
has been associated with the resistance to schistosomiasis in individuals from 
endemic regions of Brazil. For this reason, the study of the S. mansoni gene 
structure and polymorphism of Sm14 is of pivotal importance to identify the 
isoform better suited to devise an efficient vaccine. The data presented in the 
work of Ramos et al. (2003) indicate that the sequence of the various Sm14 
proteins is relatively conserved among the American strains of S. mansoni 
and provide the first experimental evidence for the existence of a reduced 
polymorphism, especially with respect to S. japonicum FABP (SjFABP). In 
particular, the single mutation M20T is the principal example in terms of 
recurrence. Interestingly, this change induces important structural and 
functional modifications in the protein that can have direct consequence in 
the development of a schistosomiasis vaccine based on this FABP. In fact, 
the more structurally stable Sm14-M20 isoform appears to be the better 
vaccine candidate. 
 
4.3 Materials and Methods 
 
4.3.1 Cloning of full-length Sm14.  
S. mansoni adult worms were freshly obtained by perfusion of mice, infected 
at least 7 weeks before, using HEPES-buffered RPMI-1640 medium and 
containing 100 U/ml of heparin. Parasites, suspended in a minimal amount of 
medium, were frozen in liquid nitrogen and ground to a fine powder. Total 
RNA was extracted in Trizol reagent (Invitrogen) of which 5 µg were treated 
with SuperScript II reverse transcriptase (Invitrogen) to synthesize cDNA, 
following the protocol recommended by the manufacturer. To obtain the 
Sm14 full length coding region, a PCR reaction was carried out on the cDNA 
template using the forward primer 5’ –
GTTGAAACATATGTCTAGTTTCTTGGGA– 3’ and the reverse primer 5’ 
–TTGCTCGAGTTAGGATAGTCGTTTATAATT– 3’. The PCR reaction 
was carried out using 1µl of template, 50pmol of each primer and 2.5U of Pfu 
DNA Polymerase (Stratagene). The PCR product obtained was subcloned 
into pPCRscript Amp SK(+) (Stratagene) after which the plasmid was 
sequenced with an ABI PRISM 310 Genetic Analyzer using the BigDye 
Terminator Cycle Sequencing Kit (ABI). The same PCR product was then 
cloned into the Gateway His-tagged E. coli expression vector, pDEST17 
(Invitrogen), following the protocol recommended by the manufacturer. 
Expression of recombinant protein was carried out in E. coli 
BL21(DE3)pLysS cells. 
 
4.3.2 Purification of Sm14.  
Wet cells of a 3l bacterial growth, were resuspended in 40 ml of buffer A 
(0.5M NaCl, 50mM Tris/HCl pH 8.0, 2mM β-mercaptoethanol, 1mM EDTA, 
2% Triton X-100 and 1mM of protease inhibitor 
phenylmethylsulphonylfluoride) (Sigma-Aldrich, all reagents were of 
analytical grade). Cell lysis was achieved after 5 min sonication at 4 °C. The 
protein was found to be expressed in inclusion bodies; hence, after 
centrifugation at 10000×g and removal of the supernatant, the remaining 
pellets containing inclusion bodies were cyclically treated three times with 
the protocol described. Water washing of the residual pellet was employed to 
remove the excess detergent. The pellets were then dissolved in 50 ml of 
buffer B consisting of 6 M urea, 20mM Tris/HCl pH 7.8, 500mM NaCl, 
5mM imidazole, 20mM β-mercaptoethanol and gently stirred overnight at 4 
°C. The resulting solution was filtered with a 0.45µm syringe filter and 
loaded onto a Ni2+-column (chelating sepharose, Amersham Biosciences). 
The bound protein was washed with 5-7 column volumes of buffer B without 
β-mercaptoethanol. A rapid change of solution with buffer C (20mM Na-
phosphate pH7.8, 500mM NaCl) resulted in a properly folded His-tagged 
Sm14, which was eluted at about 250mM imidazole by a linear gradient 
obtained by mixing buffer C with the same containing 500mM imidazole. 
SDS-PAGE (Laemmli, 1970) showed the presence of the pure His-tagged 
Sm14 characterized by a molecular mass of 18.5 kDa. Then, 50mg of pure 
His-tagged Sm14 were dialyzed against 100mM Tris/HCl pH 8.0, 250mM 
NaCl, at 4°C, concentrated to 3.5-5 mg/ml followed by addition of 0.1% 
octyl-β-glucopyranoside. The protein solution was then diluted 1:1 with 
buffer D (2M urea, 400mM NaCl, 100mM Tris/HCl pH 8.0, 10mM CaCl2, 
2mM β-mercaptoethanol) and 10U/ml of thrombin from bovine plasma 
(Sigma-Aldrich) were added. The resulting solution was stirred overnight at 
room temperature, then dialysed against 0.1M MES pH 5.5 and loaded onto a 
cation-exchange column (Source S-15, Amersham Biosciences). The cleaved 
Sm14 was eluted with a NaCl gradient at about 100mM salt and verified by 
SDS-PAGE. 
 
4.3.3 Crystallization of the complex with FAs. 
Prior to crystallization the protein was equilibrated in 10mM MES pH 5.5, 
50mM NaCl, 1mM β-mercaptoethanol. The complexes with the two FAs 
were formed by adding a 2-fold molar excess of each ligand to Sm14. FAs 
were added in ethanol to a 1mg/ml solution of Sm14, so that the ethanol 
concentration did not exceed the 1% v/v. The mixture was gently stirred 
overnight at room temperature after which the excess of ligands was removed 
by washing the sample in 3 kDa-cutoff ultrafiltration devices (Amicon) and 
the protein was subsequently concentrated to 10mg/ml. Crystallization was 
achieved using the hanging drop vapour diffusion method, employing drops 
consisting of 1µl of a well solution of 0.1M MES pH 6.0, 0.2M NaAcetate, 
29-31% PEG 8K (wt/v), 5mM β-mercaptoethanol, and 1µl of the protein 
sample. Rod-like crystals of dimensions 0.4×0.2×0.2 mm grew within few 
days at 21°C. Crystals were cryoprotected by using a solution containing 
10% glycerol (v/v), 30% PEG 8K, 0.1M MES, 0.2M NaAcetate, 5mM β-
mercaptoethanol, pH 6.0 and flash–frozen in liquid nitrogen. 
 
4.3.4 Data Collection and Processing. 
Data for the two structures were collected at ELETTRA (Trieste, ITALY) at 
100K and then processed using the HKL suite (Otwinowsky and Minor, 
1996). Both Sm14-OLA and Sm14-ACD complexes crystallized in the same 
P21212 space group with the unit cell dimensions given in Table 4.1. The 
datasets from 20.0 Å to 1.85 Å for Sm14-OLA and from 20.0 Å to 2.4 Å for 
Sm14-ACD are complete, well measured, and uniformly distributed in 
reciprocal space. Solvent volume was calculated, with the method of 
Matthews (Matthews, 1968), to be around 45% of total crystal volume, and in 
both cases there was only one complex molecule per asymmetric unit. 
 
4.3.5 Structure solution and refinement of Sm14-OLA complex.  
The structure was solved by molecular replacement techniques with the 
program AMoRe (Navaza, 2001) of the CCP4 suite (CCP4), using the 
structure of the Muscle-FABP (M-FABP) complex (PDB code 2HMB; 
Zanotti et al., 1992) as search model after removal of FA and water 
molecules. Data between 15 Å and 3.5 Å were used and gave a clear solution 
with a correlation coefficient of 0.42. Model building and electron density 
map inspection were performed with the program XtalView (McRee, 1999). 
For model building both 2|Fo|-|Fc| and |Fo|-|Fc| electron density maps were 
calculated and contoured at 1σ and 3σ levels, respectively. Most of the loops 
and the two α-helices were rebuilt. Subsequent rounds of rebuilding and 
refinement using Refmac (Murshudov et al., 1997), for 13179 reflections 
between 20.0 Å and 1.85 Å, resulted in a complete model of Sm14-OLA 
complex, with a R-value of 0.198 and a Rfree of 0.246 (see Table 4.1). OLA, 
Met 20 and the side chains of His 14, Glu 110, Asp 124 and Lys 132 were 
refined with two alternative conformations. Two additional amino acids (Gly 
and Ser) resulting from the thrombin cleavage of the polyHis tag were found 
at the N-terminus. 
 
4.3.6 Structure solution and refinement of Sm14-ACD complex. 
Since this complex was isomorphic to Sm14-OLA, the difference Fourier 
method was used to solve the structure, using Sm14-OLA, without OLA and 
waters as a model. The refinement of Sm14-ACD proceeded in a similar 
fashion to that described above. The difference density located in the binding 
cavity, was modelled as C20:4 fatty acid. Final refinement led to an R-factor 
of 0.213 and an Rfree of 0.283 for 5746 reflections between 20.0 Å and 2.4 Å. 
The final structure contained 135 aminoacid residues, 77 water molecules 
and 1 molecule of ACD (see Table 4.1) and displayed only the side chains of 
Met 20 and His 14 in double conformations. 
 
 
 
4.3.7 Structural analysis.  
The models were monitored for geometrical quality by using PROCHECK 
(Laskowsky et al., 1993). The B-factors for several structural elements were 
calculated using the subroutine BAVERAGE of the CCP4 program (CCP4). 
The contacts between FAs, residues and waters were considered up to 4.6Å 
and measured with the program CONTACT (CCP4). The r.m.s. deviations 
between structures were calculated with the program LSQKAB (CCP4). 
Volume and surface of the protein cavity were calculated with Cast-P (Liang 
et al., 1998). Sm14-OLA and Sm14-ACD structures have been deposited in 
the PDB with entry codes 1VYF and 1VYG respectively. 
 
4.3.8 Spectrofluorimetry and fluorescence-based FAs binding. 
The affinity of Sm14 for FAs was determined by taking advantage of the 
enhancement of the fluorescence quantum yield of ANS (Sigma-Aldrich) 
upon binding to Sm14 (Kirk et al., 1996). The experiments were carried out 
using a Spex Fluoromax spectrofluorimeter at 20°C in 2 ml of 0.1M MES pH 
5.5. Sample solutions of Sm14 were prepared by diluting a stock to 
concentrations of 0.1µM for Kd determinations and to 5µM for stoichiometric 
experiments. The stock solution (7mM) of the fluorescent probe was 
prepared in ethanol. Aliquots of appropiately diluted solutions of ANS in 
0.1M MES were added to the protein and mixed in a cuvette with a magnetic 
stirrer for 2 min before collecting spectra. ANS and protein concentrations 
were verified spectrophotometrically (ε280=12750 M-1cm-1 for Sm14, 
ε280=4990 M-1cm-1 for ANS in water). The excitation wavelength was 380 nm 
and emission spectra were collected over the range of 400-500 nm; emission 
peaked at 480 nm and readings between 470 and 490 nm were used for 
quantitative analyses. A 1:1 stoichiometry was achieved and the Kd 
determined to be 0.5 µM, without significant dilution of the Sm14, assuming 
simple equilibrium binding between aqueous ANS and Sm14. 
Competition experiments with FA were performed as described for the 
ANS binding measurements, starting with a protein solution containing 
4.5µM ANS as competitor. OLA, ACD, palmitic (PA), myristic (MA), 
linoleic (LA) and decanoic acid (DA) were purchased from Sigma. All the 
FAs were dissolved in ethanol to a final concentration of 10mM, then diluted 
in the experimental buffer prior to use and used within a few hours. The 
concentrations of PA, LA, OLA and ACD at the end of the titration were 
much below their CMC determined at physiological pH (Richieri et al., 
1992); presumably this applies also to DA and MA, whose CMCs have not 
been reported. Addition of FA aliquots resulted in quenching of the emission 
peak of the bound ANS. Titration curves were fitted to a simple replacement 
equation; the relative errors of the resulting Kd values (Table 4.2) lie within 
0.2%. 
 
4.3.9 Kinetic measurements, pH jump and double mixing experiments. 
Stopped-flow experiments were carried out using an Applied Photophysics 
MV18 (Leatherhead, U.K.) apparatus equipped for fluorescence signal 
detection. The excitation wavelength was 380 nm, and emission was 
collected using a filter with cut-off ≤ 455 nm. Solutions of Sm14 (0.4µM) in 
0.1M MES pH 5.5 were mixed with buffered solutions of ANS at 
concentrations ranging between 3 and 10µM at 20°C. The time courses were 
fitted to a double exponential. 
The competition measurements were performed in two ways: Sm14 
0.4µM was first incubated with ANS 50µM and mixed with different 
amounts of OLA (1.25-5µM); alternatively the protein was incubated with 
OLA (1.5µM) and mixed with different solutions of ANS (100 to 400µM). 
These experiments were carried out under sub-optimal conditions, given that 
the transmittance of the samples ranged from 56% to 10%. As a consequence 
the amplitude of the recorded signal cannot be trusted, whereas the rate 
constants are reliable. 
In pH jump experiments, a weakly buffered Sm14 solution (0.4µM) 
containing ANS at concentration ranging from 2 to 3.3µM at one pH (10mM 
MES pH 5.5 or 10mM HEPES pH 7.4) is mixed with an equal volume of a 
concentrated buffer solution at the reciprocal pH (0.1M HEPES pH 7.4 or 
0.1M MES pH 5.5). The final pH of the solutions after the pH jump was 
assessed by mixing equal quantities of the buffers. 
Double mixing experiments were carried out in order to test the time 
course of the pH dependent conformational change. Sm14 (0.4µM) dissolved 
in 10mM HEPES pH 7.4 was mixed with 0.1M MES pH 5.5, and the solution 
was “aged” for different times (ranging from 15ms to 150s). After the pre-set 
delay, the resulted solution was mixed with an equal volume of a buffer 
containing 0.1M MES pH 5.5 and 4µM ANS. 
 
4.4 Results 
 
Recombinant Sm14, when expressed in E.coli with a polyHis tag, is 
insoluble. After solubilisation of inclusion bodies with urea, refolding was 
achieved by a rapid change of buffer with the protein still bound to the Ni 2+-
column, to avoid aggregation. A non-ionic detergent (1-octyl-α-
glucopyranoside) was added to refolded His-tagged Sm14 to keep the protein 
in solution. Thrombin digestion yielded a quantitative cleavage of the His-
tag, the major element of instability; an additional purification on a cation 
exchange-column at pH 5.5 was necessary to obtain homogeneous Sm14. 
Purified Sm14-apo form did not crystallize despite extensive efforts; however 
its complexes with ACD and OLA did crystallize under the conditions 
described in the methods section. Thus the description of the protein structure 
will refer exclusively to Sm14-FA complexes. 
 
4.4.1 Overall structure 
Sm14-ACD and Sm14-OLA were solved at 2.4 and 1.85 Å respectively, with 
the two models achieving final R-factors of 21,3%and 19.8%.As assessed by 
the program PROCHECK (Laskowsky,1993; see Table 4.1 for a summary of 
crystallographic data). 
 
Table 4.1 Summary of Data collection and Refinement  
 Sm14-OLA Sm14-ACD 
Space group P21212 P21212 
no. unique reflections 13179 5746 
I/σ(I) 22.3 (4.8)a 19.6 (8.8)b 
completeness (%) 99.3 (92.7)a 95.5 (86.9)b 
redundancy 4.5 5.5 
Rmerge 0.046 (0.38)a 0.067(0.17)b 
R 0.19 0.21 
Rfree 0.24 0.28 
a Last shell (1.88-1.85Å) 
b Last shell (2.49-2.40Å) 
 
The main chain and all the atoms of the two complexes of Sm14 are 
superimposable, with an r.m.s.d of 0.32 and 0.75Å respectively. At the N-
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terminus both structures have two partially disordered amino acids, belonging 
to the linker region after the His-tag (see materials and methods). Numbering 
of the amino acids starts from the first native residue (Met 1), the two non-
native residues being Gly - 1 and Ser 0. 
The two complexes have a single molecule of either ACD or OLA, bound in 
the large internal cavity. The volume of Sm14 cavity (calculated after 
removing FA and the waters from the models) is ~300Å3 (see Table 4.2), i.e. 
comparable to the cavity volumes of other FABPs belonging to the same 
family (Zanotti et al., 1992). Similarly to the heart group of FABPs (H-
FABPs), Sm14 folds as a β-barrel formed by 10 antiparallel β-strands, named 
from A to J, following the annotation of Sacchettini et al.(1989) (Figure 4.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 Sm14 overall fold. Secondary structure elements (labelled in 
black) and the corresponding residues are: Gly 6-His 14 β-strand A, Phe 16-
Leu 23 α-Helix I, Ala 28-Thr 35 α-Helix II, Thr 39-Asp 45 strand B, Lys 48-
Ser 55 strand C, Lys 58-Cys 62 strand D, Phe 70-Lys 73 strand E, Asn 79-
Lys 86 strand F, Lys 91-Asp 98 strand G, Asn 101-Asp 110 strand H, Thr 
113-Val 120 strand I, Ile 126-Arg 131 strand J.  
Putative amino acidic residues that may interact with membranes are 
displayed in CPK view and labelled in red. 
 
The main chain of each β-strand is H-bonded to the adjacent one, with an 
interruption of this H-bond array between strands D and E, which are 
connected via their side chains. Therefore, the structure of Sm14 may be 
depicted as formed by two separated β-sheets, the first one formed by five β-
strands from A to E and the second by those from G to J. The resulting β-
barrel is twisted, closed on one side by interaction between the side chains 
and capped on the other side by a helix(I)- turn-helix(II) motif (Figure 4.1). 
The gateway for entry of the substrate in the internal cavity is constituted by 
the helix(I)-turn- helix(II) motif (residues 16-35) and by two hairpin loops 
between strands C-D and E-F (residues 56-57 and 74-78, respectively) 
(Figure 4.1). In both complexes of Sm14, the gateway appears closed, but 
binding and dissociation of FAs must depend on the opening of this doorway. 
Phe 57 on the C-D loop, which has been proposed to be a key residue in the 
binding process (Eads et al., 1993), closes the entry of the lid and is oriented 
towards the interior of the cavity in both structures. The contact distances 
between the carbons of Phe 57 and the aliphatic chain of OLA range from 3.5 
to 4.5Å; in the complex with ACD the contact distances between C14-C20 
and Phe 57 are in the range 3.9-4.5Å. In Sm14-OLA complex, Phe 57 has a 
higher B-factor (41.1 Å2), compared to the overall B factor of the protein 
(36.1 Å2), index of a certain mobility. In Sm14-ACD, Phe 57 has an average 
B factor similar to that of the whole protein (53.6 Å2). 
On the rim of the portal region, Lys 22 at the end of helix (I) and Lys 58 on 
the loop between strands C-D show the same position and orientation as that 
of their homologues in H-FABP (Lys 22, Lys 59), where they have been 
demonstrated to interact electrostatically with phospholipids head groups and 
supposed to drag the carboxylate of the fatty acid towards the internal cavity 
(Herr et al., 1996; Figure 4.1). On the external surface of Sm14 (on the back 
of the two alpha-helices), the hydrophobic side chains of Trp 27 and Ile 32 
are exposed to the solvent. This unusual orientation of Trp 27, already 
predicted for SjFABP (Kennedy et al., 2000) and confirmed by our 
structures, may help binding to the membrane, inserting among the 
phospholipids tails (Figure 4.1). Moreover, the work by Storch and Thumser 
(2000) has clearly identified the alpha-helical regions of muscle and adipose 
FABPs as being involved in the interaction with membranes. Since both our 
structures share the same orientation of the same amino acids, we may 
assume that Trp 27 and Ile 32 in Sm14 have also similar functions. 
 
4.4.2 Structure of bound fatty acids 
The internal surface of the cavity is constituted by polar and hydrophobic 
amino acids, whose side chains are mostly oriented towards the interior of the 
protein (Figure 4.2 B, D) 
Bound OLA is completely surrounded by protein atoms and by structural 
waters (Figure 4.2 B). The carboxylate is at H-bonding distance with the N( ) 
of Arg 127,the oxygen atom of Tyr 129 and two structural water 
molecules,W12 and W78. W12 is kept in that position by specific H-bonds 
with N( )of Arg 107 and the OH of Thr 116,while W78 makes H-bond with 
Thr 53. Although the relative orientation of the carboxylate, within these 
polar residues, is well maintained in most of the FABPs, the geometry of H-
bonds in the binding site is often different. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2. 3D structures of Sm14-OLA and Sm14-ACD complexes 
Panel A: Overall structure of Sm14-OLA with secondary structure elements 
highlighted. Bound OLA (in blue ball and stick) is shown in its double 
conformation. Residues belonging to the antigenic peptides are coloured in 
light grey and Met 20 is shown in magnolia ball and stick. 
Panel B: Zoom of the binding cavity with the network of H-bonds fixing the 
carboxyl head group of OLA highlighted. 
Panel C: Overall structure of the Sm14-ACD complex. Strands and helices 
are labelled as in A. ACD is shown in purple ball and stick. 
Panel D: Same as B, for Sm14-ACD complex. 
 
The complex with OLA is found in two conformations, which differ in the 
orientation of the last five carbon atoms (Figure 4.3). Conformer 1 is found to 
be in the same U-shaped conformation, previously observed for other FABPs 
(Zanotti et al., 1992; Eads et al., 1993) and occupies the same portion of the 
cavity. Conformer 2 displays a chain bending similar to that found for the 
ACD in the Sm14-ACD complex (see below) in which the last part of the 
aliphatic chain is out of the plane traced by the rest of the molecule. The 
difference maps clearly show electron density for both conformations of 
OLA. The two conformers are compatible with only slight differences in the 
positions of the first thirteen carbon atoms (Figure 4.3). The relative 
occupancy of the two is 50%,and their average B factors (43Å2)are above the 
average B factor of the side chains of the cavity in which they are buried 
(33Å2). Moreover, in conformer 1 OLA is disordered at its terminus, as 
indicated by the interruption of the electron density map between C15 and 
C16. Hairpin conformations are induced by the cis double bond between C9 
and C10, by gauche bonds between C5 and C6, C13 and C14, by the large 
number of Van der Waals interactions with side chains and with 7 ordered 
water molecules in the conformer 1 and with 6 in conformer 2. The double 
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C11
C14
C9
OLA 
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C8
C5
bond in C9-C10 interacts in both conformers with the conserved Phe 16, Met 
20 and with Val 25, Ser 75, Asp 76, Arg 78. 
 
 
 
 
 
 
 
 
 
Figure 4.3 Representation of OLA and ACD bound to Sm14. The partial 
superimposition of the C9-C10 double bond of OLA (in dark grey) and the 
C11-C12 double bond of ACD (in light grey) demonstrates a similar 
configuration of the two FAs in the binding pocket. OLA displays a double 
conformation (shown as 1 and 2). In conformer 2 the aliphatic chain adopts a 
fold similar to the ACD in which the last carbon atoms of the tail are out of 
the plane defined by the rest of the molecule; in conformer 1 the last carbon 
atom of OLA points towards the carboxylic moiety, yielding a V-shaped 
conformation. 
 
Of the 21 residues that contact OLA in conformer 1, 10 are hydrophobic and 
11 are polar. In detail: 8 residues belong to 4 of the 10 β-strands (Gln 96 on 
G β-strand, Thr 103, Ile 105, Arg 107 on H, Thr 116, Val 118 on I and Arg 
127, Tyr 129 on J), 3 of these amino acids (Arg 107, Arg 127 and Tyr 129) 
constitute the binding site of FA carboxylate, 2 residues (Val 36, Pro 38) 
come from the loop that connects helix(II) with B β-sheet, 4 lie on the mobile 
loops that form the rim of the β- barrel (Phe57 in C-D loop, Ser75, Asp76 
and Arg78 in E-F loop)and the remaining 7 belong to the helix(I)-turn-
helix(II) motif (Phe 16, Met 20, Leu 23, Val 25, Thr 29, Ile 32, Gly 33). 
ACD, like OLA, is entirely buried within the cavity with a 
100%occupancy.The electron density map is complete without interruption. 
Interestingly ACD is characterized by an average B factor (37Å2) lower than 
the surrounding polypeptide chain (48Å2), indicating a strong interaction. 
The carboxylic moiety makes the same kind of contacts as OLA (Figure 4.2 
D). ACD assumes a conformation similar to OLA conformer 2, making the 
same contacts, plus some additional ones. The contacts between ACD and the 
side chains of Thr 53, Ser 55, Lys 58 and Leu 60, characteristic of OLA 
conformer 2, are maintained, whereas the contact between Ile 32 and C13 is 
present only in OLA conformer 1.Moreover, the long chain of ACD and the 
presence of four cis double bond rigidify its structure increasing the convex 
shape and consequently the contact surface between the protein and the lipid, 
as compared to OLA (Figure 4.3). Several specific sets of contacts with 
amino acid side chains and water molecules stabilize the four double bonds 
(i.e. Phe 16,Met 20,Leu 23, Val 25,Thr 29,Gly 33,Phe 57,Ser 75,Asp 76,Arg 
78,Gln 96,Thr 103,Ile 105,W26,W39). It is remarkable that in both ACD and 
OLA complexes, the residues Met 20 and His 14 adopt two alternative side 
chain conformations; in one of those Met 20 is closer to the double bond of 
the bound FA (C9-C10 for OLA and C11-C12 for ACD). 
The double bonds at C9-C10 in OLA and at C11-C12 in ACD are found in 
the same position (Figure 4.3), interacting with the same amino acids but in 
closer contact in the ACD adduct. This is indicative of how different FAs 
arrange their aliphatic chain for a better fitting into the same protein pocket. 
Relative to the overall plan defined by the lipid, the first two double bonds 
(C5-C6, C8-C9)of ACD are out of the plane, while the last two lie in it. 
Examination of the protein-ligand interactions shows that specific polar 
contacts stabilize the first two cis-double bonds in that out-of-plane 
orientation (Figure 4.4). 
 
 
 
 
 
 
 
 
 
Figure 4.4 Network of contacts in the binding site of the Sm14-ACD complex. 
The indicated residues interact with the double bonds of ACD in C5 and C8. 
The same overall architecture is conserved in Sm14-OLA complex. 
 
It is interesting to note the continuous contact surface generated by the side 
chains and the two waters interacting with the first two double bonds of 
ACD. This architecture is maintained in Sm14-OLA structure but it is not 
suitable to allow specific interactions with a C18:1 FA. Previous studies 
showed that the couple Arg 78-Asp 76 in the E-F loop is one of the structural 
elements that help the binding process in H-FABP family (Hodson and 
Cistola, 1997). Another residue, Thr 74, at the beginning of the same loop, 
takes part to this interaction making a H-bond with Asp 76, without directly 
contacting the FA. This network of H-bonds could help bending the E-F loop 
C5 C8 
towards the interior of the protein thus stabilising FA through a strong 
directional π-cation interaction between Arg 78 and C8-C9 double bond (in 
Figure 4.4). A consistent observation is given by the B-factors of the E-F 
loop in the two Sm14 complexes. In the case of Sm14-OLA, in which the 
interaction between FA and Arg 78 is looser, the B-factors are greater by 
about 10Å2 with respect to the mean-value of the whole protein, whereas in 
the Sm14-ACD structure, they lie in the same range as the overall structure. 
In conclusion, the binding pocket is relatively rigid and does not change upon 
binding different ligands; OLA and ACD accommodate in the pocket with 
respectively lower or higher shape complementarity, due to their geometry. 
 
4.4.3 Ligand binding properties of Sm14 
We studied equilibrium and kinetics of complex formation between Sm14 
and several FAs using the environment-sensitive fluorescent probe ANS. The 
crystallographic structure of Adipocyte FABP (A-FABP)-ANS complex 
shows that this probe is located in the FAs binding site with the sulfonate 
moiety placed between the two arginines involved in the FA’s carboxylate 
binding site (Ory et al., 1999). The functional properties of Sm14 were 
characterized in 0.1M MES pH 5.5 for two reasons : (i) crystals of Sm14 
were obtained at a similar pH (see Matherials and Methods) hence granting a 
better comparison between functional and structural data and (ii) at this pH 
the protein is stable for a long time. Under these conditions Sm14 binds ANS 
with a 1:1 stoichiometry and high affinity (Kd =0.5 µM).For comparison, the 
Kd values reported for A-FABP and Intestinal-FABP (I-FABP9 ranged from 
1 to 50 µM, in several conditions (Ory et al.,1999;Kirk et al.,1996). 
Addition of FAs to the Sm14-ANS complex quenches emission at 475nm, 
indicating that FAs displace ANS. The best fit analysis of the titration data is 
achieved assuming a single FA molecule binding. The values of Kd 
calculated for 6 different length FAs are reported in Table 4.2.  
 
Table 4.2 Equilibrium constants for the dissociation of six fatty acids from 
Sm14, and cavity volumes of Sm14-OLA and Sm14-ACD. 
 
Fatty acid CMCa 
(nM) 
Kd 
(nM) 
Cavity Volume 
(Å3) 
    
Decanoic acid  (C10:0)  6100  
Myristic acid  (C14:0)  88  
Palmitic acid  (C16:0) 4,000 33  
Oleic acid  (C18:1) 6,000 9 318.9 
Linoleic acid  (C18:2) 13,000 24  
Arachidonic acid  (C20:4) 20,000 10 300.1 
 
aCritical Micellar Concentration (Richieri et al., 1992) 
 
The results show that formation of the complex between Sm14 and OLA or 
ACD have essentially the same dissociation constant: i.e. 9 and 10 nM 
respectively. The values for decanoic, myristic, palmitic and linoleic acids are 
respectively 610, 9, 3 and 2.5 fold greater than OLA and ACD. The 
maximum ANS quenching found in our experiments occurs at concentrations 
much below the FA critical micellar concentrations (CMC) as determined at 
pH 7.4 under physiological conditions (Richieri et al., 1992).This is very 
important since above the CMC the equilibrium becomes heterogeneous. The 
high affinity of FABPs for their ligands is explained because: (i) FAs are 
poorly soluble in water, hence there is a favourable free energy change 
associated with their transfer to the less polar protein interior;(ii) FAs 
establish extensive, though weak, contacts with the residues lining the 
internal cavity of FABPs, accounting for the enthalpic contribution to 
binding; and (iii) given pKa= 4.7 for the long chain FAs, all molecules are 
predominantly in the anionic form, both at pH 5.5 and at pH 7.4, thus 
favouring the interactions with the positively charged guanidine group of Arg 
127. We attempted ANS replacement experiments by addiction of 
prostaglandins, but failed to detect any fluorescence change, proving that 
Sm14 does not bind these derivatives of ACD, even at concentrations higher 
than those prevailing under physiological conditions in human body. The 
differences between the Kds reported in Table 4.2 at pH 5.5 and older data 
(Moser et al., 1991) could be rationalised by the difference in pH. Indeed 
when the same ligand titrations were carried out at pH 7.4, we observed an 
increase in Kd, by a factor of 10 or more. This reduction in affinity as the pH 
is increased applies to both ANS and FAs and may be of physiological 
relevance, helping releasing bound FAs (see below). 
The kinetic rate constants for binding and release of ANS and oleic acid were 
determined by fluorescence stopped flow; indeed when dealing with a carrier 
protein displaying such a high affinity for its ligands, the question arises 
whether release occurs to an extent and at a rate compatible with physiology. 
The combination of Sm14 with ANS (at pH 5.5) is fast, and its second order 
rate constant is  2 × 108 M-1 s-1, thus approaching the limit set by diffusion. 
Given the affinity of ANS (Kd =0.5 µM) and the sensitivity of the instrument, 
it is impossible to dilute the ligand sufficiently to obtain a more precise 
estimate. The kinetics of dissociation of ANS bound to Sm14 can be 
followed by displacement, mixing with an excess of OLA. The time courses 
recorded have half times of ~1 s and are best described by two exponentials, 
irrespective of the concentration of OLA. Although it is obvious that the slow 
fluorescence decrease observed is associated with the release of ANS, it is 
unclear whether the reaction involves a ternary complex with both ANS and 
OLA transiently bound to the protein cavity. Furthermore, the ratio between 
the overall kon and koff does not equal the equilibrium constant, suggesting a 
complex reaction mechanism. 
Release of bound OLA was achieved by rapidly mixing the complex with 70 
to 1000 fold excess of ANS (Figure 4.5).  
 
 
 
 
 
 
 
 
 
Figure 4.5 Time course of oleic acid replacement by ANS. Sm14 (0.4µM) 
incubated with OLA (1.5µM) in Mes pH 5.5 is rapidly mixed with ANS 
buffered solutions at concentrations of 100 (◊), 200 (□) and 400 µM (ο). 
Experimental points are fitted with a model including a ternary complex 
between Sm14-OLA-ANS. The slow decrease in fluorescence signal (always 
present but best seen at the highest ANS concentration) is the dissociation of 
OLA from the ternary intermediate. 
 
Even at its lowest concentration, ANS is able to displace over 50%of the 
bound OLA. The time course is complex and involves, as an unstable 
intermediate, a ternary complex of Sm14 with both ANS and OLA in the 
pocket, from which OLA would then dissociate. Accordingly, the main 
fluorescence increase could be assigned to the second order formation of the 
ternary complex (kon =3×10 6 M-1 s-1), whereas the subsequent fluorescence 
decrease (koff=3 s-1) would be assigned to the dissociation of OLA from the 
ternary complex and the coupled entrance of water in the pocket. This 
hypothesis is strengthened by data from Echinococcus granulosus FABP 
(EgFABP), a protein with high sequence identity with Sm14, which binds 
more than one ligand at pH 7.4 (Alvite et al., 2001). 
The rate of FA release from Sm14 is independent of the ionic strength of the 
medium. Consistently, Sj-FABP discharges the ligand to acceptor membranes 
by a collision mechanism via a modulation of the membrane charge without 
being influenced by the salt concentration (McDermott et al., 2002). 
Since the affinity of Sm14 for its ligands depends on pH and decreases by 
over an order of magnitude as the pH is raised from 5.5 to 7.4, it is possible 
to induce ANS binding or release by rapidly changing the pH of the solution. 
Indeed if Sm14-ANS complex in diluted buffer at pH 7.4 is rapidly mixed 
with concentrated buffer at pH 5.5, binding occurs; if the opposite pH jump is 
realized, the dissociation of ANS can be followed (Figure 4.6). 
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Figure 4.6 Dissociation of ANS, following the pH jump 5.5→7.4, monitored 
by a decrease in fluorescence. A solution of 0.4µM Sm14 containing 2µM 
ANS in 0.01M MES buffer pH 5.5 was mixed in the stopped flow apparatus 
with an equal volume of 0.1M HEPES buffer pH 7.4. 
 
Unexpectedly, after a pH-jump the change in ligand affinity occurred at a 
relatively slow rate. Indeed when Sm14 equilibrated in dilute HEPES buffer 
at pH 7.4 was rapidly mixed with a concentrated buffer at pH 5.5 containing 
ANS (Figure 4.7, Trace 1), the binding time course was slower than that 
observed with Sm14 equilibrated at pH 5.5 and mixed with ANS at the same 
pH (Figure 4.7, Trace 2).  
 
 
 
 
 
 
 
 
Figure 4.7 Trace 1: Binding of ANS at pH 5.5, monitored by an increase in 
fluorescence, is fast: a solution of 0.4µM Sm14 in 0.1M Mes buffer pH 5.5 
was mixed with an equal volume of a solution of 3.3µM ANS in the same 
identical buffer. Trace 2: The binding of ANS at pH 5.5 after an 
instantaneous pH jump 7.4→5.5 is quite different from trace 1, because the 
protein is still in the slowly reacting pH 7.4 conformational state; this was 
obtained by mixing a solution of 0.4µM Sm14 in 0.01M Hepes buffer pH 7.4 
with an equal volume of a solution of 3.3µM ANS in 0.1M Mes buffer pH 5.5. 
 This shows that the low-pH conformation, corresponding to the fast reacting 
state, was not reached during this simple pH jump experiment. Thus to 
determine the rate constant of the conformational change we carried out a 
double mixing experiment, in which Sm14 equilibrated in diluted buffer at 
pH 7.4 was mixed with concentrated buffer at pH 5.5 and then, after a 
variable delay, with ANS dissolved in buffer at pH 5.5.All time courses could 
be described by two exponentials whose rate constants are independent of the 
final pH, the relative amplitude of the processes corresponding to the two 
kinetic phases, being the only parameter that varies with pH. 
The results of this analysis are showed in Figure 4.8. The rate of the 
conformational change is 0.1 s -1. 
 
 
 
 
 
 
 
 
Figure 4.8 Fraction of the quickly reacting form (Q.R.F.) of Sm14 as a 
function of the incubation time at pH 5.5 after a pH jump 7.4→5.5. A 
solution of 0.4µM Sm14 in 0.01M Hepes buffer pH 7.4 was first mixed with 
an equal volume of 0.1M Mes buffer pH 5.5, and than, after variable 
incubation time, with a double volume of a solution of 4µM ANS in 0.1M Mes 
buffer pH 5.5. The time courses of fluorescence increase (indicating complex 
formation) were fitted to double exponentials under the assumption that the 
two kinetic rate constants were independent of the incubation time, while the 
relative amplitude of the fast and slow binding events changed. Each 
experimental point represents the fraction of fluorescence increase assigned 
to the faster kinetic process. The solid curve drawn through the experimental 
points is the best fit for a simple exponential relaxation to the equilibrium 
condition, with τ-1=0.1sec-1. 
 
4.5 Discussion 
 
4.5.1 Structure of Sm14 
Sm14 is the only vaccine candidate shown to achieve significant immune 
protection against schistosomiasis as well as against the helminth infection of 
cattle caused by F.hepatica (Tendler et al., 1996). The protein is present in all 
the life cycle stages spent by the parasite inside the definitive host, i.e. 
schistosomulum, adult worm and eggs (Brito et al., 2002).The basal lamella 
of the tegument and the gut epithelium of the worm are strongly labelled by 
immunofluorescent probes against Sm14 (data not shown). These tissues 
have a high flow of lipids, supporting the putative role of Sm14 as 
intracellular transporter of FAs from host cells (Moser et al., 1991). 
Therefore a detailed investigation of its structure and function is of crucial 
importance. 
The overall structure of Sm14 is a U-shaped β-barrel closed on top by a lid of 
helices and on the bottom by side chains, similarly to other FABPs. The 
agreement with the homology model presented by Tendler et al. (1996) is 
fairly satisfactory. We shall focus our discussion on some structural features 
relevant either to the antigenicity or to the physiological function of the 
protein. Vaccination trials in Swiss mice showed that two peptides derived 
from Sm14 are capable of inducing a level of protection comparable to that 
induced by the full length protein (Tendler et al., 1996; Vilar et al., 2003). 
The two peptides, namely Pep1 (from 85 to 94) and Pep2 (from 118 to 125), 
are topologically far from each other in Sm14 crystal structure (Figure 4.2 
A,C). Pep1, close to Sm14 bottom, encompasses F and G β-strands including 
the loop between them; Pep2 is also located in a loop, more precisely a β-turn 
between strands I and J, close to α I-helix. Most of the side chains of these 
regions are exposed to the solvent except Leu 92 and Gln 94 of Pep1 and Val 
118, Val 120 and Ala 125 of Pep2, all of which point to the interior of the 
protein. Our structures could explain the antigenicity: both peptides possess a 
unique secondary feature, which is possibly retained even when removed 
from the protein; and both appear to be sufficiently different from the 
homologous human isoforms to be recognized as “non-self”. Met 20 (Figure 
4.2 A,C) at the beginning of the α I-helix is relevant to the immunogenic 
properties of Sm14 but it is far from the two antigenic epitopes; thus its effect 
may be indirect. In both our structures, Met 20 presents a double 
conformation, with 50% occupancy. In one conformation the sulphur atom 
lies in proximity of the C9-C10 double bond in Sm14-OLA (3.8Å) and of the 
C11- C12 double bond in Sm14-ACD (3.7Å). In the other conformation the 
sulphur atom is found in between the two helices (hence out of the binding 
site). The latter conformer may play a critical role in stabilizing the closed 
conformation of the pocket lid when a ligand is bound. When Met 20 was 
mutated into Ala in two other FABPs (A-FABP and I-FABP), the proteins 
were characterized by a reduced stability and a decreased affinity for FAs by 
about 6-8 kcal/mol (Richieri et al., 1998). 
Position 20 of the polypeptide chain also presents a natural allelic variant, 
T20. Ramos and co-workers (2003) studied the effect of mutations of Met 20 
in Ala and Thr with respect to antigenicity, and observed a different 
protective response against S.mansoni cercariae in mice. Sm14-M20 displays 
greater antigenicity than physiological Sm14-T20 and artificial Sm14-A20 
(67%, 44%, 20%reduction of worm burden, respectively). Since the three 
isoforms have different thermodynamic stability, it is possible that this 
parameter could be amongst the structural determinants of the immune 
response. 
 
4.5.2 Fatty acid binding:affinity,structure and physiological implications 
The favourable free energy of FAs binding may be due to a combination of 
opposite effects: specific interactions between the protein and FA; water 
solubility of FA; loss of degrees of freedom in the binding process, with 
entropic loss. FAs aqueous solubility (CMC in Table 4.2) increases with the 
level of unsaturation for a given chain length and therefore the affinities 
might be expected to decrease with the degree of saturation, as it happens for 
most FABPs, where high Kd values correlate with high water solubility of 
polyunsaturated long-chain FAs (Figure 4.9) (Richieri et al., 2000).  
 
 
 
 
 
 
 
 
 
Figure 4.9 Behavior of the equilibrium dissociation constants (Kd) of 
intestinal FABP (in black) and of Sm14 (in red) versus critical micellar 
concentration (CMC). 
This is not the case for Sm14, whose preferred ligands are long-chain 
unsaturated FAs. In fact the physiologically important long-chain FAs have 
Kd values in the range 10-90 nM, while binding of shorter FA such as 
decanoic acid is much weaker. Interestingly, ACD is the tightest ligand for 
Sm14 despite its relatively high solubility in water (Figure 4.9). 
Previous calorimetric experiments on FABPs belonging to the same family as 
Sm14 have shown that FA binding is mostly enthalpy driven (Balendiran et 
al., 2000).Therefore the reason for a preference of ACD may lie on the 
specific contact surface and interactions between the protein and the 
substrate, the volume of the cavity being in all cases practically unchanged 
(Table 4.2). 
The number of recognition sites between Sm14 and the bound OLA or ACD 
is similar; the aliphatic chain of OLA has 18 contacts in conformer 1 and 21 
in conformer 2, and the aliphatic chain of ACD has 21. Moreover each FA 
carboxylic group makes 3 further contacts.  
The network of interactions between C5-C9 of FAs and Sm14 involves four 
side chains and two water molecules (Figure 4.4). This network is 
substantially the same for OLA and ACD, the binding cavity being 
unchanged in both structures, but in the latter case the contacts are shorter. 
The C9-C10 and the C11-C12 double bonds of OLA and ACD, respectively, 
are superimposable (Figure 4.3), making the same set of contacts with Met 
20,Val 25,Ser 75,Asp 76. The major difference in binding lies in the 
conformation of the tails of the two FAs, due to a different way of fitting into 
the cavity. Compared to ACD, OLA displays a reduced rigidity (showed by 
the double conformation and by the higher B factors) and less specific 
contact sites. The structural analysis strongly suggests that the contributions 
of enthalpy and entropy in favouring the binding of the two FAs are different. 
The binding between Sm14 and ACD could result in a larger enthalpic 
contribution, due to specific contacts and a better shape complementarity 
(Figure 4.4). Indeed, our data suggest that Sm14 is specifically designed to 
accommodate ACD. This result is intriguing given that ACD, besides being a 
nutrient, is the substrate for prostaglandin synthesis, which has been 
demonstrated to represent an additional way to escape the host immune 
response through the inhibition of Langerhans cells migration (Angeli et al., 
2001).  
The affinity of Sm14 for FAs is higher at acidic pH than at neutral or basic 
pH. The pH dependence of the ligand affinity observed in mammalian 
FABPs is opposite, e.g. A-FABP shows a higher affinity at alkaline than at 
acidic pH (Wootan et al.,1993).This finding suggests that the physiological 
role of Sm14 may be FAs transfer in the reverse direction with respect to that 
observed in mammalian cells. Moreover, like A-FABP, Sm14 is a basic 
protein (pI=7.8) and belongs to the family that transfers ligands to/from 
acceptor membranes with a contribution by collision. Previous work showed 
that A-FABP discharges ligands rapidly when acceptor vesicles contain 
acidic phospholipids, and only slowly when membranes are positively 
charged. Thus in that case a reduction of affinity at acidic pH cooperates with 
an enhanced collision probability between the protein and acceptor 
membranes in order to release FA. The authors did not discover the bases for 
changes in affinity with pH, but did not rule out conformational changes 
(Wootan et al., 1993). In Sm14, we have kinetic evidence for a slow 
conformational change induced by a sudden pH change (Figure 4.8). This 
Acidic pH 
effect may be due to a widening of the protein cavity at pH 7.4, causing a 
reduction of affinity, an observation crucial to understand the role of Sm14. 
In particular, negatively charged phospholipid head groups (located on the 
cytoplasmic side of the membranes) lower the local pH at the membrane 
surface (Eastman et al., 1989), thus triggering the conformational change of 
Sm14 to the high-affinity state. Hence we deduce that pH change next to 
anionic membrane phospholipids may have two distinct effects: (i) to 
increase the affinities of Sm14 for FAs and (ii) to facilitate collision between 
protein and membranes. 
 
 
 
 
 
 
 
 
 
 
Figure 4.10 The scheme depicts the hypothetical principal direction of FAs 
transport in S. mansoni tegument (left) and in mammalian adipocyte (right). 
The main functional difference between Sm14 and A-FABP (apart from their 
ligand specificity), is the opposite effect of pH (see text) that is suggested to 
determine the preferential direction of the FAs trafficking in the two cases. 
 
Since Sm14 is localized in tissues near the contact with the host, it is 
reasonable that its main function is to extract FAs from the host’s serum, 
where the free FA concentration is about 7nM, and to release them in the 
intracellular medium. This is consistent with the more acidic pH near the cell 
membrane and hence the higher ligand affinity of Sm14. On the contrary, A-
FABP would mainly work in the opposite direction, loading up FAs in the 
cytoplasm and releasing them near cell membranes, since its pH effect on 
ligand affinity is reversed with respect to Sm14 (Figure 4.10). Hence, we 
believe that not only different affinities among different FABP families, but 
also different pH dependences of affinity are relevant to physiology. 
FABPs markedly differ in their isoelectric points (Veerkamp et al., 1991). pI 
may lead FABPs to preferentially interact with one type of cell membranes, 
thus contributing to the physiological requirements of the tissue or organism 
in which they are expressed. Moreover, it has been shown that the uptake of 
FAs can also occur in close proximity to specific receptors (Weiseger et 
al.,2002) and in good agreement with our hypothesis, it was recently reported 
that schistosomes express receptors for human lipoproteins that display acidic 
properties (Fan et al.,2003). 
 
4.5.3 Comparison with other FABPs 
FABPs are grouped according to sequence comparison. In this classification, 
Sm14 belongs to the same family group as H-FABP [mammalian heart-, 
muscle-, brain-(B-), adipose tissue-and myelin-FABPs; parasite Sj-,and Eg-
FABP, Esteves et al., 1997]. It seems that all these proteins have higher 
affinity for polyunsaturated FAs with respect to FABPs of other groups. In 
fact the affinity of H-,B-,M-FABP is in the range 4-7nM for OLA and 18-
27nM for ACD. This is in line with our values, although Sm14 affinity for 
ACD remains the highest of the group. Interestingly, Eg-FABP, coming from 
another platyhelminth unable to de novo synthesize FAs, shows a similar 
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trend in affinities versus OLA, LA and ACD (Alvite et al., 2001). One main 
difference between Sm14 and the H-FABP group is that Sm14 affinity for 
FAs is maximal at slightly acidic pH, whereas that reported for mammalians 
is maximal at physiological pH. Several structures of FABPs are deposited in 
the PDB, most of them bound to FAs. The trend that FABPs (including 
Sm14) are easier to crystallize in the liganded state, implies that binding of 
FAs stabilizes the protein. The only two structures deposited in the PDB of 
FABP complexes with polyunsaturated FAs are human B-FABP (Balendiran 
et al.,2000)with docosahexanoic acid (DHA, 22:6)and murine A-FABP with 
ACD (PDB code:1ADL; LaLonde et al., 1994). The equilibrium constant 
measured for ACD binding to this latter protein was 4.4 µM (by means of 
calorimetry; LaLonde et al., 1994) and 196 nM (by acrylodated intestinal 
fatty acid binding protein ADIFAB method, Richieri et al., 2000).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11 Details of the interactions of Sm14 and A-FABP versus ACD  
 
A comparison between the complexes Sm14-ACD and murine A- FABP-
ACD shows that our complex is characterized by more specific contacts. In 
our structure, the double bond in C5-C6 of ACD is stabilized by a series of 
polar contacts involving 3 invariant residues and two water molecules (Figure 
4.11 B). Thr, Ile and Gln are conserved in murine A-FABP but only the 
contacts between two water molecules and C5-C6 double bond are present 
(Figure 4.11 B).  
A further important feature is the π-cation interaction between Arg 78 and 
C8-C9 double bond, which is assisted by Asp 76 in correctly orienting NH2 
of Arg 78 (Figure 4.11 A). Although these two residues are conserved in H-
FABPs family, in A-FABP their side chains do not interact in such a precise 
way with ACD as they do in Sm14 (Figure 4.11 B). Moreover, these two 
residues are not conserved in non homologous proteins, an indication of how 
much this sequence architecture is important for a preference of binding 
polyunsaturated FAs by the H-FABP group. Therefore we can explain the 
tight binding of Sm14 to ACD with these two specific networks of 
interactions: those between Gln 96, Thr 103, Ile 105, W26, W39 and C5-C6 
double bond; and those between Asp 76-Arg 78 and C8-C9 double bond. 
Moreover, the double bonds C5-C6, C8-C9, C11-C12 and C13-C14 are 
arranged in such a way around Phe 18 to permit π -stacking interactions. 
From this scenario, we conclude that the lipid-specificity of FABPs, and 
hence the details of their interactions with FAs, may vary according to the 
needs of the tissue or organism in which they are expressed. A preferential 
region for specific interactions in the complexes of Sm14 is that of the 
residues in contact with the two first double bonds of ACD (C5 and C8), 
where the network of interactions is optimized (Figure 4.11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 5 
 
 
 
 
 
 
5. CONCLUSIONS AND PERSPECTIVES 
 
 
 
 
 
 
 
 
 
 
 
In general, this work contributes to our understanding of aspects 
fundamental to the pathogenesis of the schistosome and, at the same time, 
offers new possibilities for the search of a therapy. We focused our attention 
on the parasite’s metabolism of Arachidonic acid (ACD). In fact, a product of 
this metabolism, i.e. prostaglandin D2, inhibits the host immune response 
during the first stages of infections Therefore, we selected two target 
proteins: the Glutathione S-Transferase from S. haematobium (Sh28GST), 
involved in the isomerization of prostaglandin H2 to prostaglandin D2 and the 
Fatty Acid Binding Protein from S. mansoni (Sm14) implicated in the 
transport of fatty acids (FAs) from the host blood into the parasite interior. 
In the first part of my Ph.D thesis, I presented the high resolution 
structures of Sh28GST at different GSH concentrations and the structure of 
the Y10F mutant, together with the characterization of their GSH affinities 
and their transferase activity. 
The crystal structure of Sh28GST, a member of the very well studied GST 
protein family, reveals new features concerning the role of the active site 
residues, the structure of the dimer interface, and the affinity for GSH. In 
particular, an active site residue (Tyr10) with previously well defined roles in 
structure and function was found to have additional, or perhaps previously 
unrecognized, stereochemical features. 
The non-activating conformer of the highly conserved Tyr10 at the active 
site, which was not previously identified, is especially intriguing. From 
inspection of the high resolution 3D structure and from crystallization 
experiments ranging from free, through partially saturated and than fully 
GSH saturated enzyme, the two conformers appear to change in relative 
population. Moreover, evidence from solution studies carried out on other 
GSTs, demonstrated a high conformational flexibility, especially of the 
apoprotein, and suggested that in solution interconversion of the two Tyr10 
conformers might be possible. 
The presence of this new conformer allowed us to hypothesise that Sh28GST 
is involved not only in the detoxifying/transferase activity but also in 
prostaglandin D2 synthase activity. Interestingly, both mechanisms are 
possibly common to other GSTs, at least those having a Tyr in the active site. 
The proposed mechanisms, thought still hypothetical, allow us to consider 
that niche occupied by Tyr10 in the non-activating conformer could be 
exploited in the design of inhibitors which would fill this cavity, essential to 
accommodate the phenolic ring of the catalytic Tyr10. 
In the second part of my Ph.D thesis, the 3D structure of the two 
complexes of the Sm14 with ACD and oleic acid (OLA) was solved by 
means of X-ray crystallography at 2.4 and 1.85Å of resolution, respectively. 
Moreover, we characterized the binding and release reactions of Sm14 and 
several important FAs. 
The functional and structural data of Sm14 presented in Chapter 4 enable us 
to infer its physiological role in the parasite life cycle; in the definitive host, 
Sm14 acts as a shuttle of FAs, particularly polyunsaturated ones, from the 
host serum to the parasite interior (directly or possibly through a receptor). 
The proposed mechanism implies that local pH-changes induce a 
modification of Sm14 ligand affinity through a conformational change, 
accounting for its function as a shuttle for FAs towards the cell interior. This 
information may also be exploited in the design of specific drugs, considering 
that the function of this protein is crucial for the parasite. Finally, our 
structures provide a rational explanation for the antigenicity of two peptides 
selected for vaccine trials and could guide the search for other peptides 
capable of eliciting highly protective antibodies. 
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7. PUBLICATIONS 
 
 
 
 
 
 
 
 
 
The experimental work I carried on during the three years of Ph.D., mainly 
deals with the study of the structure and function relationship of proteins 
directly implicated in the pathogenesis of schistosomiasis, the second most 
prevalent parasitic disease after malaria. This work arise from a close 
collaboration with the group of Prof. Donato Cioli at the CNR Institute of 
Cell Biology of Monterotondo, with the group of Prof. François Trottein at 
the Institute Pasteur of Lille (France) and resulted in two articles, which may 
be found in the next pages. 
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